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Abstract
The lipid bilayer forms the basic structure of the cell membrane, which is a
heterogeneous matrix of proteins and lipids that provides a barrier between the interior of
a cell and its outside environment. Protein and lipid domains in cell membranes can
facilitate receptor localization, stabilize membranes, and influence membrane fluidity. In
this thesis, we study how ordered protein and lipid domains influence the physical
properties of lipid bilayers to better understand the roles of membrane domains in
biological mechanisms. Model cellular membranes that mimic the behavior of biological
membranes offer a controllable environment for systematically studying the isolated
effects of protein and lipid ordering on membrane organization. Using fluid and solid-
supported lipid bilayers, we study ordered peripheral membrane proteins and lateral lipid
phase separation with fluorescence microscopy and X-ray reflectivity. To model cellular
protein coatings and peripheral proteins, we prepare biotin-functionalized membranes
that bind the proteins streptavidin and avidin. Fluorescence microscopy studies
demonstrate that proteins crystallized in a single layer on lipid bilayer surfaces can
change the lipid curvature and stabilize lipid vesicles against osmotic collapse. At solid
interfaces, we characterize the electron density profiles of protein-coated bilayers to
determine how a water layer separates an immobile protein layer from the fluid lipid
bilayer. Liquid-ordered lipid phases enriched in cholesterol and sphingomyelin can
localize molecules in cell membranes and this lipid phase separation behavior may be
influenced by proteins and molecules in the membrane. Caveolae are specialized liquid-
ordered domains in the plasma membrane that are enriched in the protein caveolin-1. We
demonstrate that caveolin-1 peptides influence the onset of lipid phase separation and
bind phase-separated lipid bilayers in solution. On solid surfaces, the formation of liquid-
ordered lipid phases is influenced by surface roughness; with reflectivity, we determine
that lipid bilayers containing cholesterol and sphingomyelin thicken with increasing
cholesterol content. The membrane receptor GM1 also thickens the lipid bilayer when it
is incorporated into the bilayer upper leaflet. The diverse experimental platforms that we
present are applicable to studying additional and more complex biological systems to
elucidate the influence of lipid and protein domains on cell membrane structure,
organization and fluidity.
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CHAPTER 1. INTRODUCTION
1.1 Background and Motivation
1.1.1 Function and Structure of Biological Membranes
The cell membrane provides a barrier between the interior of a cell and its outside
environment and mediates the transport of molecules into and out of the cell. A
continuous lipid bilayer is the base structure for all cell membranes and is described as a
two-dimensional fluid comprising amphiphilic phospholipid molecules [1], shown
schematically in Figure 1-1. Many of the protective and selective biological transport
functions of the cell membrane are attributed to the unique structure of the lipid bilayer
interface. Lipid molecules have a hydrophilic headgroup attached to fatty acid chains
(Figure 1-1, center) and self-assemble into bilayers. The resulting interface has a
hydrophobic core and the headgroups are exposed to the aqueous environments interior to
and exterior to the cell. The hydrophobic core limits passage of ionic molecules through
the membrane and the packed lipids resist passage of large molecules.
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Lipid Bilayer Lipid Molecule DOPC
Figure 1-1. Schematic of lipid bilayer membrane (left), a single lipid
molecule (center) and the unsaturated phospholipid
dioleoylphosphatidylcholine or DOPC (right).
The lipid bilayer serves as a fluid matrix in which membrane proteins and protein
complexes reside. Proteins are a significant part of the composition of cell membranes
and are attached peripherally or imbedded within lipid bilayer membranes [1]; the nature
of this physical arrangement can influence the overall membrane structure and fluidity
and affect the organization of surrounding lipids.
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1.1.2 Heterogeneity in Biological Membranes
In the heterogeneous cell membrane, both lipids and proteins can assemble into
ordered domains that confer spatial organization to the membrane. Lipids can laterally
phase separate into domains, membrane-associated proteins can form complexes in the
cell membrane, and lipids can assemble around proteins [2]. This ordering of proteins and
lipids into heterogeneous structures gives the overall membrane heterogeneous fluidity.
The mechanical properties of the membrane, including curvature, permeability and
stability, can be influenced by protein and lipid ordering.
1.1.2.1 Lipid Ordering in Cell Membranes
The concept of liquid-ordered lipid domains in the cell membrane has revised our
understanding of membrane organization, as lipids can self-organize into lateral phases
into which proteins can preferentially partition [3]. Lipid rafts, or detergent-insoluble
domains of the plasma membrane enriched in cholesterol and sphingolipids, are thought
to play a role in sequestering molecules to facilitate cell signaling. Interestingly, model
lipid membrane experiments demonstrate lipid phase separation very similar to cellular
membrane extracts; thus, simple lipid mixtures have provided an important basis for
understanding lipid raft formation in cells [4]. The formation of lipid rafts is thought to be
driven by packing among saturated lipids, sphingolipids and cholesterol to create a
liquid-ordered phase where different membrane molecules, including gangliosides [5],
GPI-anchored proteins [6] and crosslinked lipid-associated proteins [7], reside.
The preferential partitioning of proteins and glycolipids into liquid-ordered phases
of the cell membrane is a possible biological function of lipid rafts, where molecules
collected in a particular phase are brought into closer proximity to enable binding and
interaction. An important related mechanism is the induction of lipid phase separation by
proteins, where proteins rearrange their local lipid environment into lipid phases. Model
systems of proteins and lipids show that proteins bound to lipids can sort lipids into
liquid-ordered domains [8, 9]. Lipid shell theory suggests that nanoscopic domains of
proteins and contiguous lipids are targeted to other protein/lipid complexes to build large
liquid-ordered lipid phases enriched in selective proteins [10]. The nature of protein
interactions with phase-separated lipid membranes and the selective partitioning into lipid
domains is not completely understood. Biological examples of proteins that associate
with liquid-ordered lipid phases are caveolin-1 and cholera toxin, which binds to the
ganglioside GM1. Caveolae are domains in the membrane with invaginated morphology
that are important for lipid metabolism [11-15] that are identified by the presence of
caveolin-1. The lipid composition of caveolae is similar to rafts, though it is unclear how
caveolin-1 is targeted to these cholesterol and sphingolipids-enriched domains. Among
the membrane molecules that can be localized to caveolae fractions of the membrane is
the GMI receptor, and the cholera toxin-GM1 complex may enter the cell by uptake
through caveolae [16]. Model membrane experiments suggest that GM1 localization to
liquid-ordered lipid phases may be assisted by an induction of lipid phase separation, as
GM1 can change the temperature-mediated onset of lipid phase separation [17, 18].
1.1.2.2 Protein Ordering in Cell Membranes
Since proteins are significant part of molecular composition of cell membranes
and can interact with lipid domains, it is important to study the effect of protein ordering
on lipid bilayer membranes. Proteins that order and self-assemble in cell membranes have
many functions, including structural membrane deformation [19, 20] and transduction of
external signals [21]. The lipid bilayer membrane is a highly flexible material capable of
deforming into diverse shapes and proteins are often required to guide and direct
membrane deformation. An example of protein-assisted membrane deformation is
endocytosis, where the budding of the membrane into vesicles [19, 22] is assisted by the
protein clathrin. The assembly of clathrin molecules into a well-defined lattice on the
cellular membrane surface forms invaginations termed clathrin-coated pits that bud into
the cell [23-25]. Similarly, transport vesicles that bud from the endoplasmic reticulum to
traffic proteins in the cell are formed by insertion of the GTPase Sarlp into in the bilayer,
which disrupts lipid packing and expands the area of the outer membrane leaflet [26, 27].
Caveolae are also part of an endocytotic pathway, though the filamentous protein coat
found in caveolae and how it deforms the membrane is less understood [28, 29].
Monomolecular surface layers on archae and bacteria, termed S-layers, may play a role in
the sieving of molecules crossing the membrane and physical protection of the cell [30].
Modification of the lipid bilayer is also an important biological function attributed to
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membrane-associated proteins. Phospholipase A2 binds lipid bilayers and catalyzes the
hydrolysis of phospholipids into fatty acids and single-chained lipids, thus changing the
lipid composition and increasing membrane heterogeneity [31]. As part of its mechanism
to gain entry to cells, the B subunit of bacterial cholera toxin binds the membrane
receptor GMI, forming pentagonal complex that eventually forms a pore through which
cholera toxin crosses the membrane [16].
In this thesis, we examine both lipid and protein ordering in model lipid bilayer
membranes. Our model membrane experiments, which allow us to isolate the effects of
lipid ordering and protein-lipid interactions, may help us to understand how domains in
cell membranes are important to the overall biological function of the membrane. We
present studies of lipid ordering in fluid membranes in Chapter 3, where we study
peptides derived from caveolin-1 interacting with model lipid rafts to understand how
proteins can influence lipid phase separation. In Chapter 4, we study protein ordering and
its influence on the shape and stability of lipid bilayer vesicles. In Chapters 5 and 6, we
present our experiments combining X-ray reflectivity and fluorescence microscopy to
study planar supported lipid bilayers. We combine these microscopic and nanoscopic
techniques to study ordered proteins tethered to bilayers in Chapter 5. And in Chapter 6,
we examine how a model membrane receptor influences the structure of the lipid
membrane and we study the structure of bilayers with model lipid rafts.
1.2 Model Biological Membrane Systems
Due to its complexity and the diversity of protein and lipid molecules present, the
cell membrane is impossible to re-create artificially. Model biological membranes that
attempt to mimic the structure and function of cell membranes are thus commonly used in
experimental investigations; these model membranes can be monolayers, bilayers or
multilamellar membranes. Lipid monolayers spread at the air-water interface comprise a
single bilayer leaflet and can be studied with microscopy, neutron and X-ray reflectivity
and surface-sensitive optical techniques [32]. Multilamellar stacks of bilayers are often
used in calorimetry [33] and X-ray and neutron reflectivity studies [34, 35]. In this thesis,
we exclusively use model systems based on a single lipid bilayer, either supported on
surfaces or in the fluid phase. The single lipid bilayer most closely mimics the native
structure of biological membranes and, unlike multilamellar membranes, is appropriate
for studying surface-bound protein complexes.
1.2.1 Biomimetic Lipid Bilayer Membranes
We synthesize model lipid bilayer membranes to mimic the structure of cell
membranes and to investigate how lipid and protein ordering impacts lipid bilayer
membrane fluidity and structure at microscopic and nanoscopic scales. Chapter 2
describes our methods of preparing and characterizing model lipid bilayers.
Planar Supported Lipid Bilayers
The supported lipid bilayer (SLB) is a single lipid bilayer deposited onto a solid
surface with a thin water layer separating the bilayer and substrate, shown schematically
in Figure 1-2. The advantage of using an SLB as a model biological membrane is that the
planar surface is convenient for microscopy as well as surface-sensitive techniques
including surface plasmon resonance spectroscopy and ellipsometry [36]. If a sufficiently
flat and reflective substrate is used, then neutron or X-ray reflectivity is possible [37, 38].
A possible disadvantage of the SLB is that the mobility of the inner leaflet may be
affected by its proximity to the surface. In addition, transmembrane proteins and lipids
may interact with the substrate [39]. These mechanical coupling effects, however, may
also appropriately model cell membranes that are tethered to a cytoskeletal matrix [40].
L
Supported Lipid Bilayer (SLB) Lipid Bilayer Vesicle
Figure 1-2. Schematic of planar supported lipid bilayer (left) and
spherical lipid bilayer vesicle (right).
1.2.1.1
Lipid Bilayer Vesicles
Unilamellar lipid bilayer vesicles are spherical fluid membranes of a single lipid
bilayer, illustrated in Figure 1-2. The length scale L is used to classify the sizes of
vesicles: for small unilamellar vesicles (SUVs), L is -1-50 nm, large unilamellar vesicles
(LUVs) have L -100-500 nm and for giant unilamellar vesicles (GUVs), L is -1-100 gtm.
The larger dimension of GUVs is similar to cells; thus GUVs are often used to model
cells [41].
1.2.2 Model Systems of Lipid and Protein Ordering
We study two general model systems for lipid and protein ordering: cholesterol-
enriched membranes that phase separate into liquid-ordered and liquid-disordered phases
and two-dimensional crystalline protein bound to lipid bilayers.
1.2.2.1 Model Lipid Rafts
One of the interesting initial outcomes in studies of lipid phase separation in
model membranes is that the simple ternary mixture of DOPC, sphingomyelin and
cholesterol demonstrates phase separation behavior very similar to that found in complex
mixtures of cell extracts [4]. The chemical structure of these lipids and an illustration of
their phase separation are depicted in Figure 1-3. DOPC is a symmetric unsaturated lipid
and is enriched in the less-dense liquid-disordered (Ld) phase. The denser and thicker
1.2.1.2
liquid-ordered (Lo) phase is enriched in sphingomyelin and cholesterol. The packing of
the Lo phase may be driven by hydrogen bonding between the cholesterol and saturated
phospholipids or sphingomyelin [42] or complexation between sphingomyelin and
cholesterol [43].
%J
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Figure 1-3. Lipid structure and schematic of model lipid rafts in a
phase-separated lipid bilayer.
The Lo and Ld phases appear below the lipid mixture's melting temperature Tm;
phase diagrams demonstrating how Tm depends on the lipid composition for
cholesterol/BSM/DOPC and similar ternary systems further illustrate the ability of lipids
to self-organize within a bilayer and to demonstrate complex phase behavior [44, 45]. It
has also been suggested that lipid molecules can organize around proteins to modulate the
segregation of the membrane into Lo and Ld phases [10, 46]. The established phase
diagram behavior of cholesterol/BSM/DOPC provides a well-characterized system for
studying how proteins and peptides interact with phase-separating lipid mixtures [47]. In
Chapter 3, we investigate the partitioning and phase behavior of cholesterol/DOPC/BSM
lipid bilayer membranes containing peptides derived from the scaffolding domain of
caveolin-1. We study the scaffolding domain because of its function in attaching
caveolin-1 to membranes and interacting with lipid phases in cell membranes [48]. We
also develop an assay for measuring how peptides bind and impact the phase diagram of
phase-separating lipid mixtures.
While lipid mixtures of cholesterol/BSM/DOPC membranes in fluid vesicles
readily phase-separate into microscopic domains, lipid phase separation on solid-
supported membranes is more complicated. Stable microscopic lipid domains exist on
SLBs [4, 49-51] and the lipids are mobile; however, the domains themselves tend to be
immobile [49, 50]. In cell membranes, microscopic domains are not typically observed
[52] and lipid rafts are believed to be nanoscopic [53]. In Chapter 6 we study lipid
mixtures of cholesterol/BSM/DOPC with X-ray reflectivity and fluorescence microscopy
to measure how lipid compositions change lipid packing, density and fluidity. We also
measure membrane thickening and reduced fluidity when the model membrane receptor
GM1 (Figure 1-4) is inserted in SLBs. GMI binds cholera toxin B (CTB) with
pentagonal symmetry. The diffusion of GM1 in the membrane and the formation of this
complex precedes the entry of CTB into cells to induce disease [16]. GM1 can be
localized in cellular caveolae, enabling CTB binding and cholera toxin uptake into the
cell through caveolae.
cholera toxin B
!0
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Figure 1-4. Structure of GM1 ganglioside and schematic of GM1 as
receptor binding cholera toxin B.
Model Ordered Protein Domains
Investigations of protein ordering using model biological membranes gives
insight into two-dimensional ordering on a fluid substrate and proteins' influence on the
physical properties of lipid membranes. Bacterial surface proteins reconstituted on lipid
bilayer vesicles form rigid two-dimensional crystals that deform the membrane into
conical and cylindrical shapes [54]. S-layers re-crystallized on vesicles stabilize the
membrane against rupture [55]. Similarly, streptavidin crystallized on lipid bilayers
deforms and stiffens the membrane [56]. The molecular detail of reflectivity studies can
refine mechanisms of how proteins influence the physical properties of the lipid bilayer.
Reflectivity experiments with ordered proteins interacting with lipid monolayers show
how ordered proteins rearrange and intercalate the lipid molecules [57-60]. At the
microscopic scale, fluorescence microscopy studies of streptavidin tethered to lipid
membranes illustrates how membrane fluidity [61], ionic strength [62], pH [63] and
surface diffusion [64] can impact protein ordering in two-dimensional systems.
We use the streptavidin-avidin model system to investigate two-dimensional
protein ordering and its impact on lipid membrane fluidity in GUVs and SLBs.
Streptavidin forms two-dimensional crystalline domains when bound to biotin-
functionalized lipids incorporated in a stearoyloleoylphosphatidylcholine (SOPC) bilayer.
Streptavidin is a tetrameric globular protein that binds biotin in at two sites per side.
Avidin is a protein with biotin-binding structure and activity similar to that of
streptavidin [65] but does not readily crystallize. Fluorescently-labeled avidin provides a
bright background for visualizing streptavidin crystal formation. Figure 1-5 shows the
20
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biotin-functionalized lipid structure and illustrates streptavidin ordering on biotinlyated
lipid bilayers.
UI
SOPC biotin-X-OPPE
streptavidin
U avidin
Figure 1-5. Lipid structure and schematic of streptavidin-biotin model
system for studying protein ordering. Streptavidin and fluorescently-
labeled avidin bind the biotinylated lipids, the streptavidin forms two-
dimensional crystals.
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Previous studies of streptavidin ordering on GUVs demonstrate that streptavidin-
coatings on GUVs stiffen the bilayer and deform vesicles into prolate shapes [56, 62]. In
Chapter 4, we explore how protein domains align and deform lipid bilayer vesicles with a
size-dependent mechanism. We also demonstrate that crystalline protein confers vesicle
stability against osmotic pressure.
To complement our studies of crystalline proteins on GUVs, we also present
structural studies of streptavidin bound SLBs with fluorescence microscopy and X-ray
reflectivity. While previous reflectivity studies demonstrate how proteins arrange and
interact with lipid monolayers [66], the recent ability to characterize single lipid bilayers
at the solid support using X-ray reflectivity [38, 67, 68] provides an opportunity to study
single protein layers on a single SLB. Studying model peripheral proteins at bilayers
offers a more biologically-relevant lipid interface than monolayers. In Chapter 5 we study
streptavidin and avidin bound to a single biotinylated SLB with X-ray reflectivity.
Fluorescence microscopy characterization of the samples provides direct evidence of
crystal formation and allows us to quantify the lipid bilayer fluidity.
In addition to their role in fundamental studies for elucidating biological
processes, the lipid bilayer systems we present also have potential applications in
biosensing and drug delivery. Ordered proteins on membranes have potential application
in biosensing, where a template of functionalized proteins can be immobilized on vesicles
[55] or on planar bilayers. Stable SLBs at the solid interface have potential lab-on-a-chip
applications, where a single membrane directly coupled to a surface can be used for
detection and measurement of molecular binding events [69].
1.3 Thesis Overview
We describe our preparation and characterization of these different model
biological membrane systems, both vesicles at supported bilayers, in Chapter 2. The
subsequent chapters describe our investigations of protein and lipid ordering in different
model system. The first model biological membrane system that we present is caveolin-1
peptides interacting with ordered lipid phases in fluid vesicles. We determine the phase
partitioning behavior and lipid phase diagram of caveolin- 1 peptides in bilayer vesicles in
Chapter 3. We continue studies of lipid bilayer vesicles in Chapter 4, where we examine
how streptavidin influences vesicle shape and stability by ordering and self-arrangement.
Streptavidin ordering on lipid bilayers is presented in more structural detail in Chapter 5,
where we use X-ray reflectivity to study the structure of supported lipid bilayers coated
with a protein layer comprising streptavidin and avidin. We then use reflectivity to
examine the influence the membrane receptor GM1 and its influence on lipid and
membrane structure in Chapter 6, and we present our reflectivity investigation of the
structure of cholesterol-enriched lipid membranes.
CHAPTER 2. EXPERIMENTAL
METHODS
2.1 Preparation of Biomimetic Membranes
All lipid solutions for experiments are prepared in high performance liquid
chromatography-grade (HPLC) chloroform. Solutions are transferred only with glass
pipettes and stored in teflon-sealed sterile glass containers.
2.1.1 Electroformation of GUVs
Giant unilamellar vesicles (GUVs) are spherical lipid bilayers that are 1-100 tm
in diameter. GUVs can be visualized by optical microscopy and they are used to model
cellular membranes, because they are a size comparable to that of cells [70]. The
electroformation method for synthesizing giant unilamellar vesicles (GUVs) produces a
high yield of GUVs [71, 72]. As depicted schematically in Figure 2-1, a dry lipid film on
a conductive substrate is hydrated in aqueous solution; upon application of a gentle AC
field, large bilayers swell from the film to form GUVs.
dry lipid film
sugar swelling solution
Figure 2-1. Schematic of GUV electroformation (left) and difference
interference contrast micrographs of GUVs (right). 10 pm scale bar.
We use electroformation for the preparation of GUVs. Indium tin oxide- (ITO)
coated substrates purchased from Prdizisions Glas and Optik GmbH (Iserlohn, Germany)
are rinsed with detergent and sonicated 30 min in deionized (DI) water. Approximately
40 ptL of lipids in chloroform at a concentration of 5 mg/mL are spread on the ITO plates;
the lipid film is dried 2 h in a vacuum chamber. The dried plates are placed parallel 5 mm
apart in a Teflon holder filled with swelling solution and connected to a function
generator with 1 V AC, 10 Hz signal (Figure 2-1). The AC signal is applied 1.5-2.5 h to
form GUVs. To provide density and optical contrast and allow for osmotic stressing, we
form the GUVs is a sugar solution. For upright microscopy, GUVs are filled with glucose
then re-suspended in sucrose; the GUVs then float to the top of the viewing cell.
Similarly, sucrose-filled GUVs are used for inverted microscopy experiments. We place
the vesicles in chambers created from CoverWell silicone gaskets purchased from Grace
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Bio-Labs (Bend, OR) sealed to coverslips. All surfaces are soaked for 30 min in 1 mg/mL
bovine serum albumin solution to prevent GUVs from adhering to surfaces.
2.1.2 Extrusion ofLUVs
Large unilamellar vesicles (LUVs) are 1-100 nm in diameter and created by the
extrusion method [73], where lipids are forced through uniform pores of a polycarbonate
filter, resulting in LUVs with monodisperse size distributions. LUVs can be spread on
substrates to form supported lipid bilayers (SLBs) by the vesicle fusion method [74, 75].
Lipids in chloroform are placed in a clean glass vial and initially dried with N2
then completely dried for 8 h in a vacuum chamber. The dried lipid film is hydrated in an
aqueous solution for a final lipid concentration of 1 mg/mL then agitated on a vortex
mixer to completely hydrate the film; this suspension is heated to 40 OC for 1 h. The lipid
suspension is then passed through a 100-nm polycarbonate filter 10 times using the
Avanti Mini-Extruder from Avanti Polar Lipids (Alabaster, AL). Extruded LUVs are
discarded after 5 days.
2.1.3 SLB Preparation
Supported lipid bilayers (SLBs) are prepared by vesicle fusion, where LUVs
adsorb and rupture on substrates, or by spin-coating of lipids from organic solution
directly onto substrates followed by hydration.
All supported lipid bilayers (SLBs) are prepared on silicon substrates 20 x 15
mm 2 in size and 675 pLm thick cut from polished 6" silicon wafers with a 100-nm thick
thermal oxide layer. The substrates are cleaned by sonication for 10 min in isopropanol
followed by rinsing with DI water then a three-stage chemical cleaning treatment. First,
the substrates are boiled in acetone for 10 min at 100 0C, then in a mixture of 1:1:5
H20 2/HCI/H 20 by volume for 15 min at 150 0C, then in 1:1:5 H20 2/NH 40H/H20 for 15
min at 1500 C. After each step, the substrates are rinsed with DI water. The substrates are
stored in DI water until the SLB formation procedure.
Microfluidic chambers, shown schematically in Figure 2-2, are used for solution
exchange and the formation of protein layers on SLBs and also serve as our platform for
microscopy and X-ray measurements [37, 67]. Plastic chambers with two reservoirs
connected by a channel of dimensions 5 x 0.4 x 50 mm are purchased from ibidi GmbH
(Minchen, Germany). The chambers are cleaned before use with isopropanol. An area of
20 x 15 mm 2 is milled into the center of the channel for embedding the SiO2 substrates.
The microchannel minimizes the amount of reagents required and the fluid reservoirs
ensure constant hydration of the SLBs, as hydrated SLBs are destroyed if air bubbles
enter the chamber and contact the surfaces.
X-ray beam
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Figure 2-2. Schematic of microfluidic chamber used to prepare and
study SLBs. The SLB on the SiO 2 substrate is measured with
reflectivity and visualized with fluorescence microscopy.
2.1.3.1 Vesicle Fusion
The vesicle fusion method is used to spread LUVs onto substrates to form
homogeneous lipid bilayers [74-76]. Clean substrates are first secured in microfluidic
chambers using two-component UHU epoxy glue that hardens in 5 min (Biihl, Germany).
After the allowing the epoxy glue to pre-dry for 30 min, the chambers with glued-in
substrates are placed under vacuum for 6 h for final hardening.
We use osmotic concentration gradients to assist in the rupture of the LUVs to
form SLBs, as illustrated in Figure 2-3. LUVs are extruded in solutions with modified
HEPES buffer (10mM HEPES, 100mM NaCl, 2mM MgCl2, 2 mM CaCl2, pH 7.4). The
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microfluidic chamber is then filled with this buffer and -200 PtL of LUV solution are
pipetted into the channel and left undisturbed 30 min to allow LUVs to adsorb to
substrate. The substrate is then rinsed with DI water, causing the LUVs to rupture under
osmotic stress to form the lipid bilayer. The layer is heated to 35-40 "C for at least 2 h to
anneal the membrane.
adsorption rupture spreading
Figure 2-3. Schematic of vesicle fusion illustrating adsorption of LUVs
on surface (left), rupture from osmotic stress (middle), and spreading
to form SLB (right).
2.1.3.2 Spin-coating
We are not able to reproducibly produce homogeneous and fluid lipid bilayers
with the vesicle fusion method for lipid mixtures containing the ganglioside GMI or
biotin-functionalized lipids. For these molecules, we use the alternative preparation
procedure of spin-coating of lipids from organic solution [77, 78] to prepare single SLBs
on our substrates. We prepare 3 mg total lipid in chloroform in clean glass vials; the
chloroform is then evaporated from each vial in a nitrogen stream followed by evacuation
in a vacuum chamber for at least 12 h. Dried lipids are then re-dissolved in isopropanol to
a final concentration of 1.5 mg/mL. This concentration ensures the formation of a
complete single bilayer [77]. Unlike chloroform, isopropanol completely wets the
hydrophilic silicon substrates.
To coat the substrates, 200 gpL of lipid solution is dropped onto a clean silicon
substrate in a Delta 10 spin-coater from BLE Lab Equipment (Radolfzell, Germany).
The substrate is immediately accelerated with the following profile: a ramp from 0 to
2000 rpm is driven for 2 s, followed by another ramp from 2000 to 3000 rpm for 2 s.
Then the sample is spun at constant velocity of 3000 rpm for another 118 s. The
substrates are then placed in a vacuum chamber for at least 4 h to ensure complete
evaporation of the isopropanol. Dried spin-coated substrates are then glued into
microfluidic chambers with two-component UHU epoxy glue and dried in air for 30 min,
then in vacuum for 6 h. The SLBs are hydrated by flushing the microfluidic chambers
several times with DI water to ensure that excess lipids are flushed away.
2.2 Microscopy
2.2.1 Differential Interference Contrast Microscopy
In order to study the shapes of GUV samples that do not have fluorescent
contrast, we use differential interference contrast (DIC) microscopy. We obtain DIC
images of GUVs using a Cooke SensiCam digital camera (Cooke Corporation, Romulus,
MI) and a Zeiss Axioplan fluorescence microscope with 40x and 100x objectives
(Oberkochen, Germany). We form GUVs in glucose solutions and dilute them in sucrose
to provide optical and density contrast. DIC micrographs are analyzed using ImageJ
software (NIH, Bethesda, MD).
2.2.2 Fluorescence Microscopy
Fluorescently-labeled lipids, proteins and peptides in our lipid bilayers are
visualized with fluorescence microscopy. The lipid Texas Red 1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine, triethylammonium salt (TR-DPPE) from Invitrogen
(Carlsbad, CA) provides constrast for fluorescence microscopy. TR-DPPE is relatively
photostable and identifies phase-separation by selectively partitioning into less-dense or
liquid-disordered phases [79]. For visualizing peptide and proteins structures in lipid
bilayers, we require dyes of a different color. Alexa Fluor 488 conjugate (Alexa488-
avidin) from Invitrogen provides fluorescent contrast to visualize protein ordering. We
use FITC-labeled peptides to study peptide partitioning into lipid phases.
2.2.2.1 Lipid Phase Diagrams
To determine the lipid phase diagram of GUVs made from phase-separating lipid
mixtures, we observe miscibility transitions with fluorescence microscopy and a heating
stage [44, 45, 79]. Phase separation and domain morphology on the surface of the GUVs
are visualized using a Nikon Diaphot inverted microscope with 100x objective equipped
with a microscope heating stage unit (Instec, Boulder, CO) and an objective collar heater
(Bioptechs, Butler, PA). We measure the sample chamber temperature with a
thermocouple (Omega, Stamford, CT). The miscibility transition temperatures are
measured by both heating and cooling. We calculate the fractional area of the GUV
surface occupied by fluorescently-labeled phases using ImageJ software. Images are
thresholded to distinguish bright and non-fluorescently-labeled phases. As described
elsewhere [80], the geometry of the system prevents the use of automated algorithms for
calculating the relative fractional areas of each phase, as the threshold level must be
adjusted individually for each GUV. We therefore analyze at least 20 different GUV
surfaces are analyzed to determine the average fractional area of phases at each
composition.
Continuous Bleaching
We use the continuous bleaching method to measure the fluidity of SLBs with a
standard fluorescence microscope setup [67, 81]. We visualize and characterize SLBs in
microfluidic chambers with a portable Zeiss Axiotech vario fluorescence microscope
(Oberkochen, Germany) equipped with 10x (NA 0.3) and long distance 63x (NA 0.75)
Plan-Neofluar objectives. Images are captured with an ORCA C4742-95 CCD camera
and WASABI imaging software from Hamamatsu Photonics (Tutzing, Germany). ImageJ
software is used to determine the fractional area coverage of crystalline protein and to
estimate protein domain size. We align a HBO 103 Hg lamp from Zeiss to ensure even
illumination of the sample. Continuous bleaching data are analyzed with MATLAB
software from Mathworks (Cambridge, MA). The theory of continuous bleaching and
data analysis are explained in detail in Chapter 5.
2.2.3 Fluorescence Confocal Microscopy
In order visualize lipid phase separation and protein ordering on GUVs in three-
dimensions, we use confocal fluorescence microscopy. All fluorescence confocal
microscopy experiments are performed at the W.M. Keck Microscopy Facility at the
Whitehead Institute with a Zeiss laser scanning module (LSM) microscope with a Zeiss
C-Apochromat 40x water immersion objective with numerical aperture (NA) of 1.2. For
two-channel experiments, the excitation light from lasers at 488 nm and 543 nm is
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reflected by a dichroic mirror (HFT 488/543) and the emission is split by another dichroic
mirror (NFT 490) into two channels and passed through a 505-719 emission filter in the
first channel and a 558-719 emission filter in the second channel to detect the green-
labeled species and TR-DPPE, respectively. For the one-channel experiments of FITC-
labeled peptides, we use a 488-nm laser and a LP 505 filter. For three-dimensional image
projections of vesicles, z-scans are taken in 0.45-jtm increments and projected using
Zeiss LSM software.
2.3 Fluorescence Correlation Spectroscopy
Fluorescence correlation spectroscopy (FCS) is the time-correlated measurement
of the fluctuation of fluorescence intensity in an illuminated volume. FCS is employed to
measure the diffusion constants of lipids and proteins in biological membranes [82, 83].
We use FCS to measure the binding of a fluorescently-labeled peptide to LUVs in
solution [84]. As depicted in Figure 2-4, left, the peptide freely diffuses in an illuminated
volume with a characteristic diffusion time, 'D,peptide and, when bound to a large LUV, the
peptide diffuses with the characteristic diffusion time of the LUV, rD,LUv. Analysis of the
autocorrelated fluorescence intensity indicates the relative amounts of peptide diffusing
free in solution and bound to LUVs (Figure 2-4, right).
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Figure 2-4. Schematic adapted from [84] of the FCS measurement of
peptide binding to LUVs in solution (left) and a two-component
autocorrelation function (right).
We measure the characteristic diffusion times of the free peptide and the LUVs in
separate experiments using a Zeiss ConfoCor2 instrument with 40x Apochromat water-
immersion objective. In order to prevent adhesion of the LUVs to surfaces, we treat Lab-
Tek chamber slides by filling them with 1 mg/mL bovine serum albumin dissolved in
water for at least 30 min then air-drying the chambers before filling them with our FCS
samples. The incident laser power is 160 ptW for all experiments; we verify that
photobleaching does not affect the measurements by measuring control samples at 480
[tW laser power. A sugar buffer solution of 100 mM glucose with 5 mM KCl is used for
all FCS measurements and calibrations. The focus volume is calibrated with Rhodamine
6G for experiments at 488 nm and with Cy5 at 633 nm. To adjust the pinhole, the time-
correlated fluorescence intensity spectra for 100 nM fluorescent dye in solution is
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measured. After pinhole adjustment, the volume of the focus is determined by measuring
10 consecutive correlation spectra, each 30 s long, with 30 nM solution of calibration
dye. The known dye concentration, fraction of molecules in the triplet state T and triplet
time rTr of the calibration dye and the diffusion constant of water D are used to determine
the dimensions of the focus volume from the time-correlated fluorescence intensity
measurement from the equation [84]:
2
1 1 T e /CT'G(1)= lx g()=--x l+ Ce 1 (2-1).
N N 1-T 1+ t /TD, 1+ r/S2 rD
The number of particles in the focus volume is N, the correlation time of the dye is D=
o2/4D, where co is the radius of the focus volume and S is ratio of the radial and axial
distances from the center of the laser focus beam. We fix the structural parameter in
Equation 2-1 with the value measured from our calibration; since our experiments
involve LUVs, which we expect to have a longer diffusion time than free dyes in
solution, we measure all samples with LUVs for at least 60 s. Diffusion times for LUVs
at each lipid composition are determined by measuring LUVs containing 0.01 mol % of
the lipophilic fluorescent dye 1,1 '-dioctadecyl-3,3,3',3'-
tetramethylindodicarbocyanine,4-chlorobenzensulfonate salt (DiD, Invitrogen) at 633 nm
excitation. To use FCS to quantify the binding of fluorescent peptides to LUVs, the
peptide concentration should be proportional to the number of particles detected in the
focus volume, N. Measurement of N over a range of peptide concentrations, as shown in
Figure 2-5, indicates peptide solubility as monomolecular units and characterizes the
signal/noise ratio to determine the appropriate linear measurement regime. In our
experiments of soluble peptide binding to LUVs presented in Chapter 3, characterization
of this linear detection range (Figure 2-5, red line) motivated our choice of peptide
concentration of 50 nM to study binding to LUVs.
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Figure 2-5. The number of particles in the FCS volume plotted as a
function of concentration of peptide to indicate measurement range
appropriate for quantitative determination of peptide binding.
2.4 X-ray Reflectivity
X-ray reflectivity measurements are performed at the undulator beamline ID 1I at
the European Synchrotron Radiation Facility (ESRF) in Grenoble, France. Sample
chambers are mounted in a horizontal scattering geometry with a vertical plane of
incidence; the X-ray beam geometry is shown in Figure 2-6; a top view of the
microfluidic chamber is shown in Figure 2-2. We identify the interface and the center of
rotation of the substrate for each sample before measurement. For reflectivity studies of
SLBs on SiO 2, we choose an X-ray energy of 19.9 keV (X = 0.623 A) for the grazing-
incidence beam.
attenuator
storag
nng
thickness
200 pm
-200 pm
~5 nm
_SiO2 100 nm
Figure 2-6. X-ray reflectivity geometry used to study a SLB interface
in a microfluidic channel.
The beam cross section is limited by a pre-sample aperture of 200 x 1000 [tm 2
(vertical x horizontal). The relatively large beam size ensures a wide illumination of the
surface area even at higher grazing incidence angles. Evacuated beam guides with
Kapton windows (Figure 2-6) positioned in close proximity to the sample chamber
minimize air scattering. The reflected intensity is collected with a Nal point detector. The
loss of X-ray beam intensity by transmission through the chamber is less than an order of
magnitude and the small vertical post-sample aperture completely suppresses parasitic
contributions due to reflectivity from the top plastic foil of the sample chamber [37].
We take different measures to minimize X-ray beam damage; at full beam
intensity, beam damage is apparent and results in reduced surface coverage of the
membranes [37]. These data also provide a basis to compare to reflectivity scans to
identify possible beam damage qualitatively. To minimize damage, we position automatic
attenuators in front of the chambers to reduce the beam intensity (Figure 2-6). Each
reflectivity scan is also performed on a fresh spot and an automatic shutter prevents
exposure to X-rays during motor movements.
The reflectivity data are analyzed using Parratt's method [85] and presented with
Fresnel normalization: the reflectivity is divided by the Fresnel reflectivity (RF), where
RF = 1- 1-(qc/q)2 )/( 1+ 1-(qc/qz) ) 2  (2-2).
The momentum transfer at the critical angle of total external reflection is qc and qz is the
momentum transfer perpendicular to the interface. To fit our measured reflectivity we
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model the bilayers as a stack of slabs with varying thickness (z) and density (p),
positioned between water and the SiO 2 substrate. The thickness and number of slabs
appropriate for modeling varies with the different protein and lipid mixtures; the different
slab models used to fit the data from our SLBs are described in Chapters 5 and 6. For a
homogeneous single supported lipid bilayer, we use 7 slabs: each leaflet has 2 slabs
representing the headgroup and another slab for the acyl chain region; the interleaflet
space is an additional slab. Using the software Parratt32 (Hahn Meitner Institute), we fit
our reflectivity data to determine the electron density profile, p(z), for our specified
number of slabs. An example of the 7 slabs used to represent a SLB of SOPC is shown in
Figure 2-7. To model the electron density profile to N slabs, we use the following
equation:
p(Z)= 2 pi pi+ 1 erf ZZ (2-3).
i~l 2
The slab profiles are smoothed by an overall roughness, r. For our substrates, we use
- = 3 A. The electron density profile for our 7 slab model fit to SOPC is shown in Figure
2-7 (blue curve).
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Figure 2-7. Electron density profile of SOPC (blue curve) and the
corresponding 7 slabs between the water and SiO2 used to model the
lipid bilayer. Each slab has density p; and thickness zi and the electron
density profile p(z) is smoothed with surface roughness a = 3 A.
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CHAPTER 3. MODEL PEPTIDE
INTERACTIONS WITH ORDERED
LIPID PHASES IN LIPID BILAYER
VESICLES
3.1 Introduction
Lipid rafts, or detergent-insoluble domains of the plasma membrane enriched in
cholesterol and sphingolipids, are thought to play a role in sequestering various
molecules to facilitate cell signaling. Caveolae are a specialized type of lipid raft with
flask-like invaginated morphology enriched in the protein caveolin-1 that participate in
cell signaling and lipid metabolism [11-15]. Caveolin-1 has been shown to bind
cholesterol [86] and associate with sphingolipids [87] and may have a structural role in
the formation of caveolae [29, 88].
Model lipid rafts in synthetic lipid bilayers have provided a basis for
understanding cholesterol-enriched phases of the plasma membrane. Lipids extracted
from cell membranes and reconstituted in giant unilamellar vesicles (GUVs) exhibit
microscopic phase coexistence with lipid domains resembling ternary lipid mixtures of
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cholesterol, phosphatidylcholine and sphingomyelin [4]. In this widely-studied model
system, liquid-ordered (Lo) domains are formed from the packing among saturated lipid
acyl chains and cholesterol and are immiscible with liquid-disordered (Ld) domains
enriched in phosphatidylcholine [45]. These Lo lipid domains are considered models of
lipid rafts in the plasma membrane. Various physical properties of model lipid rafts,
including composition, morphology and molecular mobility have been studied [45, 83].
There has also been an increasing effort to understand how proteins partition into either
the Lo phase or Ld phase [47]. What remains to be well-studied, however, is how peptides
and proteins influence the lipid phase behavior of these model lipid rafts.
Proteins are significant part of the composition of cell membranes and it is
therefore important to consider proteins in model studies of lipid rafts and caveolae.
Studying the interplay between proteins and lipid phase separation may give insight into
the formation of lipid rafts, as proteins have been suggested promote domain formation
by associating with certain lipids [89]. It has also been suggested that lipid molecules can
organize around proteins and modulate phase separation [10, 46]. Using model lipid
membranes, researchers have studied how proteins and peptides can cause lateral
redistribution of lipids in bilayer membranes using differential scanning calorimetry
(DSC) [89] and fluorescence microscopy [17]. An advantage of fluorescence microscopy
is that it allows one to directly observe the lipid phase partitioning of labeled molecules
as well as microscopic phase separation.
In this study we investigate the partitioning and phase behavior of lipid bilayer
membranes containing caveolin-1. We selected caveolin-1 because caveolae are enriched
in the lipid raft components cholesterol and sphingomyelin and the membrane interaction
of caveolin-1 is not well understood. Mutagenesis experiments have identified the
caveolin scaffolding domain (CSD) as the region of caveolin-1 responsible for membrane
binding and targeting the full-length protein to caveolae [48]. The CSD comprises amino
acids 82-101 of the N terminal domain of caveolin-1 and has been shown to associate
with detergent-insoluble membrane fractions assayed in vivo [90]. We have selected
model peptides derived from the CSD of caveolin-1 to study phase separation and the
influence of cholesterol concentration on peptide-lipid interactions in lipid bilayers.
In previous model membrane experiments, the full-length CSD formed
cholesterol-enriched domains in model membranes composed of DOPC, the acidic lipids
phosphatidylserine and phosphatidylinositol-4,5-biphosphate (PIP 2), and cholesterol [91].
Subregions of the CSD and their membrane interactions have also been previously
investigated. In live-cell mutagenesis experiments, KYWFYR was shown to be the
membrane-attachment sequence [90] of caveolin-l and in recent model membrane
experiments, authors have demonstrated using DSC that KYWFYR does not promote
local high cholesterol concentrations nor does it bind cholesterol in phosphatidylcholine
membranes [33]. DSC analysis has been used to study the peptide N-acetyl-VTKYWFYR
amide, which was shown to promote local cholesterol crystal formation and depletion
from other domains, though this effect was more pronounced with the full-length CSD
[92]. The effect of acidic lipids [91, 93] and cholesterol [91, 92] on the spatial
organization and binding of CSD peptides has been investigated; thus, our primary goal is
to study caveolin-1 in model membranes with defined Lo and Ld domains and to
investigate how the CSD can impact the phase behavior of Lo and Ld phases.
Sphingomyelin is a component of caveolae in vivo [87] and thus we focus on a membrane
containing sphingomyelin in order to understand caveolin and lipid interactions.
3.2 Materials and Methods
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), cholesterol and brain
sphingomyelin (BSM) are purchased from Avanti Polar Lipids, TR-DPPE and DiD from
Invitrogen. Rhodamine 6G and Cy5 dyes in sugar solutions (Merck, Darmstadt, Germany
are used for FCS system calibration. Lipids are dissolved in HPLC-grade chloroform and
methanol from either Fluka (Switzerland) or Mallinckrodt (Phillipsburg, NJ). All other
chemicals used are reagent grade. We purchase fluorescently-labeled synthetic peptides
containing sequences derived from the caveolin scaffolding domain (CSD) from SynPep
(Dublin, CA) and the MIT Biopolymers Laboratory. The CSD is peptide labeled at the N
terminus with fluorescein isothiocyanate is FITC-CGIWKASFTTFTVTKYWFYR-acetyl
(CAV-CSD). A shorter fluorescently-labeled peptide containing the membrane-
attachment segment amino acid sequence residues 89-101 is FITC-FTTFTVTKYWFYR-
acetyl (CAV-INSOL). The soluble peptide containing these residues is synthesized with
an FITC label at the N-terminus and the sequence SGS between the FITC and CSD
residues to improve peptide water solubility without adding net charge resulting in a final
peptide structure of FITC-SGSFTTFTVTKYWFYR-acetyl (CAV-SOL). All peptides are
purified using HPLC. The pI's of the three peptides were estimated to be in the range
9.5-10.5 [94]. The structures of the three peptides are shown schematically in Figure 3-1.
N terminus 1 -187 terminus Caveolin-1
FITC CGIWKASFT ; T VTVW!K acetyl CAV-CSD (Cav-1 83-101)
FITC-SGS TTVTKYWFYR acetyl CAV-SOL (Cav-1 89-101)
FITC FT IIVTKYWFYR acetyl CAV.INSOL (Cav-1 89-101)
Figure 3-1. Schematic of fluorescently-labeled synthetic peptides.
We prepare giant unilamellar vesicles (GUVs) with the electroformation
technique [95] described in Chapter 2. Approximately 40 pL of lipid solution is spread
onto conductive indium tin oxide plates and dried under vacuum. To this lipid mixture,
we add 1 mol % of the water-insoluble caveolin-1 peptides CAV-CSD or CAV-INSOL.
We visualize the lipid phases by adding 0.1 mol % of TR-DPPE to the lipid mixture. The
GUVs are grown in a 100 mM sucrose and 5 mM KCl solution for 1.5-2 h at a
temperature above the lipid miscibility transition temperature. We form large unilamellar
vesicles (LUVs) using the extrusion technique [73] and dried lipids are then rehydrated in
100 mM glucose and 5 mM KCI. This solution is passed 10 times through two 100-nm
polycarbonate filters using the Avanti Mini-Extruder.
To determine the lipid phase diagram, miscibility transitions are observed using
fluorescence microscopy [44], as described in Chapter 2. The stock GUV solution is
diluted approximately twofold with 100 mM glucose and 5 mM KCI, to provide density
contrast. Sample heating over a temperature range of 100 C-50"C is accomplished by our
microscope heating stage unit. The miscibility transition temperatures are measured both
by heating and cooling and the error bars represent the range over which phase
miscibility was observed. In order to observe the impact of the water soluble CAV-SOL
peptide on microscopic phase separation, the soluble peptide is dissolved in glucose
buffer and added to GUVs in solution. The fractional area of the GUV surface occupied
by the DOPC-enriched liquid phase is calculated using ImageJ software.
3.3 Fluorescence Correlation Spectroscopy
Recently, fluorescence correlation spectroscopy (FCS) has been used to measure
the binding between large unilamellar vesicles (LUVs) and water-soluble peptides in
nanomolar concentrations [84]. We employ this FCS peptide-membrane assay to measure
the binding of fluorescently-labeled water-soluble CAV-SOL peptide to LUVs with only
slight modifications. Attaching the water-soluble FITC peptide to the end of the caveolin
scaffolding domain peptide away from the membrane attachment sequence should
minimize the influence of the fluorophore on the peptide-membrane binding. As a control
experiment, we verifiy that the binding of free FITC to membranes is negligible for the
lipid compositions used. The calculation of molar partition coefficients from FCS data is
outlined [84]. The expression for the normalized time correlation function G(t) is in
reference [96]:
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The average number of fluorescent molecules counted in the laser focus is N and to is the
diffusion time of the molecules. The fraction of fluorophores in the triplet state is T, the
triplet lifetime is Tr, and the structural parameter, S, is the ratio of the radial to axial
distances of the center of the laser beam to the edge of the focus volume. The triplet
fraction of the FITC-labeled peptide is -0.7 and the triplet lifetime is -3.5 pts. From
Rhodamine 6G calibration measurements, we determine S=5.5.
In our experiments, both bound and free peptide diffuse within the laser focus
volume, so the autocorrelation function is described as a weighted sum of the
contributions from the CAV-SOL peptide in solution (P) and the CAV-SOL peptide
bound to LUVs (V):
G(r)= A,g, (r)+ Avg,(r) (3-2).
We fit each correlation function with independently-measured diffusion times for CAV-
SOL peptide (rD,P = 40 ps) and fluorescently-labeled LUVs (rD,v - 5000 jIs). The
amplitudes for the summed correlation functions are determined by fitting the
autocorrelated data with the diffusion times for the free peptide and the bare LUVs to
Equation 3-3.
The molar partition coefficient of the peptide K is a proportionality constant
between the fraction of peptide bound to the membrane [P]mem and the molar
concentrations of peptide [P] and lipids [L] in solution and is described by [P]mem =
K[P][L] [84]. K is computed from a material balance on the free [P] and membrane-
bound peptide [P]mem [84]:
[P]mem K[L]ac
mm= c_ = 1-APNO (3-3),[P]tot 1 + K[L],c=
where [P]total is the sum of [P]mem and [P], [L]acc is 50 % of the total lipid concentration,
or the approximate concentration of lipids in the outer leaflet of the LUVs that is
accessible to the peptide, Ap is determined from fitting Equation 3-3 and No is the number
of peptides in the focus volume counted in the absence of LUVs.
3.4 Results
3.4.1 Caveolin-1 Peptide Phase Partitioning
All of the caveolin-1 peptides we study partition into the liquid-disordered (Ld) or
cholesterol-poor phase over a range of cholesterol concentrations. The evidence for this
partitioning is twofold, demonstrated by (1) the binding of peptides to the majority phase
and (2) the colocalization of peptides with the liquid-disordered phase marker, TR-DPPE.
Figure 3-2 demonstrates that the water soluble CAV-SOL peptide at concentration 50 nM
added to GUVs in solution binds the majority phase, or the Ld phase of GUVs containing
15 mol % cholesterol, 37.5 mol % DOPC and 37.5 mol % BSM (Figure 3-2, 1 and II) and
20 mol % (Figure 3-2 III a). We also verify that the lipid raft marker, TR-DPPE, does not
affect the partitioning of CAV-SOL into the Ld phase (Figure 3-2, I and II). The binding
of the water-soluble CAV-SOL protein to the Ld phase is further indicated by the
colocalization of CAV-SOL and TR-DPPE, which partitions into the less-dense phase of
GUVs containing 20 mol % cholesterol, 40 mol % DOPC, 40 mol % and 0.1 mol % TR-
DPPE (Figure 3-2 II1). The equatorial fluorescence confocal micrographs in Figure 3-2
III indicate that the CAV-SOL peptide is evenly distributed throughout Ld phase. Figure
3-3 illustrates how both CAV-INSOL (Figure 3-3, a and c) and CAV-CSD (Figure 3-3, b
and d) added to lipid mixtures at concentration of 1 mol % similarly partition into the Ld
phase marked by TR-DPPE. The control experiment in which TR-DPPE is omitted from
the lipid mixture is also performed with the CAV-INSOL and CAV-CSD peptides.
III
Figure 3-2. Confocal micrographs of CAV-SOL binding to the liquid-
disordered phase. Equatorial (column 1) and three-dimensional
reconstruction (column II) micrographs of different GUVs containing
15 mol % cholesterol, 1:1 DOPC/BSM. (Column III) Equatorial
micrographs of GUVs composed of 20 mol % cholesterol and 0.1 mol
% TR-DPPE. (a, green) 488 nm wavelength laser excitation channel
showing CAV-SOL peptide, (b, red) 543 nm laser excitation showing
TR-DPPE and (c) merged images. Scale bars are 20 pm.
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Figure 3-3. Fluorescence micrographs of CAV-INSOL (a,c) and CAV-
CSD (b,d) binding liquid-disordered phase in GUVs containing 10
(a,b) and 20 (c,d) mol% cholesterol, 1:1 DOPC/BSM. Scale bars are 20
pm.
3.4.2 Caveolin-1 Binding
We further investigate the binding of CAV-SOL to lipid bilayers with the
fluorescence correlation spectroscopy-peptide binding assay. Lipid bilayers with varying
cholesterol concentration and a fixed 1:1 DOPC/BSM ratio are formed as extruded large
unilamellar vesicles (LUVs). There is an approximately two order of magnitude
difference between the measured diffusion time of CAV-SOL (40 us) and the average
diffusion time of the LUVs (5000 ýus), allowing us to fit the data as a sum of two
autocorrelation functions. Increasing the cholesterol concentration decreases the diameter
of LUVs extruded from mixtures of cholesterol, DOPC and BSM. The hydrodynamic
radii (Rh) measured for DiD-labeled LUVs composed of cholesterol and an equimolar
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DOPC/BSM ratio are shown in Table 3-1. An increase in cholesterol concentration
corresponds to a decrease in Rh.
Lipid Composition Rh of LUVs K [Ml]  Area% of Ld phase
20% chol + 1:1 DOPC/BSM 91 + 4 nm -6 x 104 43 + 16
30% chol + 1:1 DOPC/BSM 89 + 4 nm -3 x 104  22 + 13
40% chol + 1:1 DOPC/BSM 78 + 3 nm -1 x 103 no phase separation
50% chol + 1:1 DOPC/BSM 75 + 3 nm -7 x 102 no phase separation
Table 3-1. Molar partition coefficients calculated from FCS data.
To systematically investigate the effects of phase separation and cholesterol
concentration on CAV-SOL-membrane interaction, we use FCS to study the binding of
50 nM CAV-SOL to membranes in solution. The autocorrelation curves in Figure 3-4
demonstrate the binding of CAV-SOL to LUVs. CAV-SOL binds more strongly to
vesicles that have phase-separating lipid mixtures (Figure 3-4, c and d) and lower
cholesterol concentrations than those in a single phase region with higher cholesterol
concentrations (Figure 3-4, e andf). We calculate molar partition coefficients from FCS
data (Table 3-1) and show how lower cholesterol concentrations and phase separation
increase the membrane-peptide interaction.
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Figure 3-4. FCS data of CAV-SOL peptide binding to LUVs. (a,b)
FCS data measured for CAV-SOL in solution with and without four
compositions of LUVs at accessible lipid concentration of 100 pM
containing cholesterol and an equimolar ratio of DOPC and BSM.
The FCS data for peptides in the presence of LUVs containing 20 mol(c), 30 (d), 40 (e) and 50 (/) mol % cholesterol, 1:1 DOPC/BSM, fitted
with 2-component autocorrelation functions.
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3.4.3 Caveolin-1 Peptide Phase Diagram
The pseudo-ternary lipid phase diagrams for the DOPC/BSM/cholesterol system
with and without the addition of the caveolin-1 peptides are presented in Figure 3-5. The
ratio of DOPC to BSM is fixed at 1:1. The miscibility transition temperature, Tm, is
measured over a range of cholesterol concentrations with and without added peptides.
Both liquid-liquid and liquid-solid phase coexistence are observed. Solid-liquid
coexistence is observed only in GUVs with cholesterol concentrations of 10 mol % or
less and solid domains are identified by their non-circular morphology, rigid body
rotation and inability to ripen into larger domains [44]. In contrast, liquid domains have
round, fluctuating edges and can coalesce and form larger domains.
The nearly identical miscibility transition temperatures measured over a range of
concentrations with and without CAV-SOL peptide indicate that the addition of CAV-
SOL does not affect the phase diagram (Figure 3-5 a). By contrast, inclusion of the
insoluble caveolin-1 peptides in the GUV membrane does depress Tm for the liquid-liquid
transition. As illustrated in Figure 3-5 b, the addition of 1 mol % CAV-INSOL and CAV-
CSD to GUVs containing 25 and 30 mol % cholesterol causes a significant decrease
(>5 0 C) in Tm. At a composition of 30 mol % cholesterol, not all of the GUVs in the
observation slide are phase separated after reaching the lower limit of the microscope
cooling stage. The addition of the CAV-INSOL and CAV-CSD to GUVs containing 10
mol % cholesterol does not cause significant change in Tm at the solid-liquid to liquid-
liquid phase transition.
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Figure 3-5. Influence of caveolin peptides on partial lipid phase
diagrams of GUVs of different cholesterol concentrations and fixed
1:1 DOPC/BSM ratio; Lo + Ld liquid-liquid phase coexistence region
shown. (a) CAV-SOL does not impact on phase diagram. Tm plotted
for for GUVs lacking peptide at transitions from liquid-solid phase
coexistence (diamonds) and liquid-liquid phase coexistence (circles,
solid curve) to single liquid phase. Tm measured for liquid-solid (*)
and liquid-liquid (squares, dotted curve) transitions after addition of
50 nM of CAV-SOL. (b) Insoluble peptides influence the liquid-liquid.
melting transition T. for solid-liquid transition at 10 mol %
cholesterol with no peptide (diamonds), 1 mol % CAV-INSOL (+), 1
mol % CAV-CSD (star) and 50 nM CAV-SOL (*) added to GUVs.
The liquid-liquid Tm was measured at 20, 25 and 30 mol % cholesterol
with 1 mol % CAV-INSOL (triangle point up, dashed curve), 1 mol %
CAV-CSD (triangle point down, dash-dotted curve) and 50 nM CAV-
SOL (squares) added to GUVs.
Figure 3-6 illustrates how the size and shape of the liquid-ordered domains are
qualitatively the same with or without peptides present. The bright cholesterol-poor Ld
phase is labeled with TR-DPPE, which is excluded from the cholesterol-rich phase [4,
44]. The circular shape of the cholesterol-rich domains indicates liquid-liquid phase
coexistence with high line tension [44] both with and without peptides.
Figure 3-6. Fluorescence micrographs of GUVs containing 20 mol %
cholesterol, viewed for TR-DPPE marking the Ld phase with no
peptide added (a), 50 nM CAV-SOL added to GUVs in solution (b), 1
mol % CAV-INSOL (c) and CAV-CSD (d) included in lipid mixture.
Scale bars are 20 pm.
3.5 Discussion
We study the phase partitioning behavior of peptides derived from caveolin-1, a
protein known to reside in membrane fractions resembling lipid rafts, but whose exact
lipid raft targeting mechanism is not well understood. We investigate the phase
partitioning of caveolin-1 peptides in a model membrane system with defined lipid
domains of differing compositions and densities. Cholesterol-rich liquid-ordered (Lo)
phases formed from ternary mixtures of BSM, DOPC and cholesterol provide a model
system for studying lipid rafts. The composition and morphology of model lipid domains
can be studied through lipid phase diagrams [45], which may give insight into the
physical properties of lipid rafts in cell membranes. Lipid domains in cells may serve as
platforms to locally concentrate molecules such as proteins to enable cell signaling. The
preference of a protein for either the Lo domain or the DOPC-enriched liquid-disordered
(Ld) domain is dictated both by the physical properties of the protein and the lipid
domain.
3.5.1 Exclusion of Peptides from Lo Lipid Domains
We find that both the soluble and insoluble caveolin-1 peptides partition into the
Ld phase at all studied lipid compositions. The fact that caveolin-1 peptides prefer the
fluid Ld domains to the dense Lo domains may be due to their exclusion from the tightly-
packed Lo domains. Lo domains are more densely packed than Ld domains due to the
alignment of the long and saturated fatty acid tails of the sphingolipid molecules and the
intercalating cholesterol. The packing of the liquid-ordered phase may be due to
hydrogen bonding between the cholesterol and saturated phospholipids or sphingomyelin
[42]. Recently, Radhakrishnan and McConnell proposed a model accounting for
cholesterol and lipid interactions using cholesterol-saturated lipid complexation and
predicted the tie lines of a three-phase lipid diagram [43]. The tight molecular packing
and acyl chain alignment within Lo domains may create a local ordered environment that
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does not readily accommodate additional molecules. This phenomenon of model peptide
exclusion from Lo domains has been previously studied experimentally. The linker for
activation of T cells protein is believed to associate with rafts in vivo, but it prefers the Ld
phases in model membranes studied both using fluorescence microscopy and detergent
resistance [97]. Detergent assays demonstrate that model peptides, including hydrophobic
transmembrane peptides [98, 99] and palmitoylated peptides [98], are excluded from
detergent-insoluble fractions due to tight lipid packing in the detergent-resistant phase.
The exclusion of our caveolin-1 peptides from the Lo phase may also be due to
our peptides' lack of lipid anchor moieties and their inability to form oligomers. There
are some general trends associated with proteins and peptides that have been shown to
partition into Lo lipid phases [47]. In model phase-separated membranes, the cholesterol-
binding protein NAP-22 is only targeted to Lo domains in its myristoylated form [100]. In
detergent resistance studies, lipidated peptides with multiple acyl chains partition into
detergent-insoluble Lo membrane phases [101, 102]. While the C-terminus of caveolin-1
contains three palmitoylated residues, the scaffolding domain we studied does not contain
such lipid anchors. An additional important feature of proteins and complexes that have
been shown to partition into Lo phases is their ability to oligomerize or form higher-order
assemblies. A well-studied example of this effect is the B subunit of the protein cholera
toxin (CTB), which binds the ganglioside GMI with pentameric symmetry and is
localized in Lo domains [7]. A recent study suggests that the CTB-GM1 complex
localizes to Lo domains only upon complex formation [9]. Using antibodies to cross-link
saturated phospholipid analogs causes the lipids to show increased affinity for Lo phases
in model lipid membranes [7]. Human placental alkaline phosphatase (PLAP) has a
glycosylphosphatidylinositol anchor and researchers have shown that cross-linking PLAP
favors its partitioning into Lo domains [82]. The scaffolding domain of caveolin-1 alone
is insufficient for oligomerization; in addition to the CSD, residues 61-101 of the N
terminus [103] and residues 168-178 in the C-terminal domain are necessary for
oligomerization of caveolin-1 constructs in vivo [104]. Recent work in live cells suggests
that the oligomerization of caveolin-1 is important for the protein to exit the Golgi
complex, to acquire detergent insolubility and to associate with the plasma membrane
[105]. The oligomerization of caveolin-1 and the formation of caveolin filaments that are
anchored into the membrane are responsible for the invaginated morphology of cellular
caveolae [19, 28, 106, 107]. We do not observe measurable changes in lipid curvature or
domain morphology when we included caveolin-1 peptides in our lipid membranes. Our
peptides' inability to form oligomers and their lack of lipid anchor moieties also
precludes the deformation of the membrane into highly-curved invaginations.
The result that our caveolin-1 peptides are excluded from the Lo phase is less
surprising for the shorter peptides CAV-SOL and CAV-INSOL, which lack the full-
length CSD that is necessary to target caveolin-1 constructs to caveolae in vivo [48]. We
also demonstrate, however, that CAV-CSD does not partition into Lo domains in our
model membrane system. In the in vivo investigation of CSD constructs targeting to
detergent-assayed raft domains, the CSD was targeted to rafts only 20% as efficiently as
full-length caveolin-1 [48]. While detergent extraction is the standard assay for
determining whether proteins prefer the Ld or Lo phase in cells [108], some question
whether detergent resistance can be used to determine whether a protein resided in a
domain prior to detergent extraction [109]. Another concern in comparing the live cell
membranes and their detergent extracts to model membrane systems is bilayer
asymmetry. The two leaflets of the cell plasma membrane have asymmetric lipid
compositions and densities, which are not preserved in the detergent extraction process
[110]. Model membranes approximating the lipid composition inner leaflet of the plasma
membrane, where caveolin-1 is thought to bind, do not phase separate into Ld and Lo
phases [111]. Previous model membrane experiments demonstrate that CSD peptides can
reside in membranes regions enriched in cholesterol, PIP2 and acidic lipids [91], yet our
model membrane system is substantially different. The defined immiscible Lo and Ld
lipid domains studied here differ in molecular density and contain sphingomyelin, a
known component of cellular caveolae [87]. The tight molecular packing in the Lo
domains excludes CAV-CSD from the Lo domains. Our results may also suggest
limitations associated with using model lipid rafts to approximate cholesterol-rich
domains in cellular membranes. Recent reviews highlight the gaps in our understanding
of lipid rafts in controlled model systems and rafts in cellular membranes [109, 110, 112].
The tendency of our caveolin-1 peptides to associate with less-dense membrane
domains is further demonstrated by FCS experiments with CAV-SOL. The water
solubility of CAV-SOL allowed us to quantify the binding of this peptide to membranes
with varying cholesterol concentrations using FCS. In our assay, the peptide is added to
LUVs in solution and binds more strongly to LUVs with phase-separating lipid
compositions (20 and 30 mol % cholesterol, 1:1 DOPC/BSM) than non-phase-separating
lipid compositions (40 and 50 mol % cholesterol, 1:1 DOPC/BSM) (Table 3-1). The
peptide's enhanced binding to membranes containing the Ld phase over homogeneous
membranes with high cholesterol content (40, 50 mol %) is consistent with the preference
of CAV-SOL for less-dense and more fluid membranes. Our measured molar partition
coefficients for CAV-SOL binding to LUVs are -104 M-1 for phase-separated lipid
mixtures and -103 M-' for non-phase-separating lipid mixtures. We measure the relative
area fraction of the Ld phase in GUVs (Table 3-1) and doubling the area fraction of the Ld
phase to which CAV-SOL binds approximately doubles the molar partition coefficient.
Our measured molar partition coefficients are similar to those measured with a shorter
caveolin-1 peptide containing residues 92-101 bound to vesicles with low (1-10 mol %)
acidic lipid compositions measured by sucrose gradients and radiolabeling of peptides
[93].
The observation of lipid phase separation in mixtures of cholesterol,
sphingomyelin and DOPC can give insight into the fluidity and ordering of membranes.
In these model studies domains are defined as microscopic immiscible phases with
simple morphologies [113]. The lipid miscibility transition temperatures of lipid phases
can be influenced by the length of lipid acyl chains [79] and clustering of protein
molecules [17]. We study the miscibility transition of membranes containing cholesterol,
BSM and DOPC and caveolin-1 peptides to study how the peptides influence Tm and the
morphology of the lipid phases. We show that the water-soluble peptide has negligible
impact on the phase diagram and the insoluble peptides depress Tm at cholesterol
concentrations above 20 mol %.
3.5.2 Changes to Lipid Phase Diagram Induced by Peptides
We demonstrate that the phase diagram and phase morphology of membranes
with 1:1 DOPC/BSM ratio and different cholesterol compositions are unaffected by the
addition of CAV-SOL peptide (Figs. 3-5 and 3-6). The identical miscibility transition
temperatures measured over a range of lipid compositions with and without CAV-SOL
(Figure 3-5 a) indicate that CAV-SOL does not moderate the relative amounts of
cholesterol nor does it redistribute the lipid concentrations in the two phases and that
CAV-SOL is unable to induce the formation of cholesterol-rich phase-separated domains
in non-phase-separated lipid bilayers. We attribute this lack of impact on the partial phase
diagram to the weak-to-moderate binding of the CAV-SOL peptide to membranes. We do
not expect CAV-SOL to penetrate deeply into lipid bilayer membranes. The interaction
of similar caveolin-1 peptides and lipid bilayer membranes has been previously studied
both with model membrane systems and in vivo. The membrane attachment sequence of
caveolin-l is KYWFYR and was identified through mutagenesis experiments and posited
to insert into inner membrane leaflet of cells [90]. The same sequence KYWFYR was
subsequently investigated with NMR was less inserted into model membranes composed
of cholesterol in SOPC membranes than a peptide comprising the well-characterized
cholesterol-binding sequence LWYIK [33]. These same authors also demonstrate that
longer caveolin-1 peptides with sequence VTKYWFYR and the full CSD do not
penetrate into SOPC and cholesterol membranes as deeply as LWYIK [92].
Unlike CAV-SOL, the insoluble peptides CAV-INSOL and CAV-CSD decrease
Tm at cholesterol concentrations greater than 20 mol % (Figure 3-5 b). CAV-INSOL and
CAV-CSD incorporated into cholesterol/BSM/DOPC membranes prevents the formation
of Lo phases at miscibility transition temperatures observed without the peptides. We
expect that the mechanism of the insoluble peptides interacting with membranes in our
experiments to be different than how the water-soluble peptide binds membranes. Unlike
CAV-SOL experiments where peptides were added to pre-existing lipid membranes in
solution, CAV-INSOL and CAV-CSD are included in the lipid mixture prior to forming
membranes and were therefore able to access the full depth of the membranes and
interact with all molecules in the lipid mixture. Phase separation is thought to be driven
by the tendency of sphingolipids to interact with cholesterol and form ordered domains
[3, 43, 114] and our results suggest that CAV-SOL and CAV-INSOL disrupt this phase
separation process. The decrease in Tm that we observed at the liquid-liquid to single
liquid phase transition suggests that the addition of the insoluble peptides to the
membranes also increases the fluidity of the membrane by promoting a single
homogeneous phase.
3.6 Conclusions
The widely-used model lipid raft system of cholesterol, DOPC and a saturated
lipid or sphingolipid may give insight into lipid rafts in cells and the formation of liquid-
ordered phases enriched in cholesterol. Studying the temperature- and composition-
dependence of lipid phase separation may improve our understanding of how proteins
affect lipid packing and mobility. The insoluble caveolin-1 peptides CAV-INSOL and
CAV-CSD depressed the melting temperature of liquid lipid phases, suggesting that the
insoluble caveolin-1 peptides prevent the lateral organization of lipids at certain
temperatures and therefore promote membrane fluidity. This effect contrasts the result
that CAV-SOL added to membranes in solution did not impact the partial phase diagram.
Model liquid-ordered domains have a dense molecular environment that is unfavorable to
caveolin-1 peptide insertion. The insoluble scaffolding domain is excluded from the
liquid-ordered phase, despite its earlier demonstrated preference for cholesterol in model
membranes [91] and its localization to detergent-insoluble fractions of cell membranes
[48]. We attribute the partitioning of our caveolin-1 peptides into liquid-disordered
domains to their exclusion from the tightly-packed liquid-ordered domains and their
preference for more fluid membranes. Overcoming the exclusion of molecules from the
tightly-packed liquid-ordered domains may be achieved by lipid anchor moieties or
oligomerization. While the full-length protein both oligomerizes and has palmitoylation
sites, our peptides lack these features.
CHAPTER 4. PROTEIN ORDERING
ON LIPID BILAYER VESICLES
4.1 Introduction
Proteins are often required to guide and direct the deformation of cell membranes
and induce structural transformations important for biological processes including
endocytosis [19, 22]. One such protein is clathrin, which assembles on the cellular
membrane surface into a well-defined lattice to form invaginations termed clathrin-coated
pits that eventually produce internal buds that are part of the endocytotic pathway [23-
25]. This physical process is driven by the fact that the curvature of the clathrin protein
lattice exceeds that of the membrane and is believed to influence the size of the clathrin-
coated vesicles that are formed [24, 25]. In addition to their role in biological processes,
protein arrays on lipid bilayers also have potential application in biosensing and drug
delivery, where a well-defined template of proteins can be immobilized on vesicles [55].
Model systems of proteins on lipid bilayer membranes allow for systematic study
of how protein arrays self assemble and influence lipid membrane shape and curvature.
The tetrameric protein streptavidin also forms two-dimensional crystalline domains when
bound to the surface of biotin-functionalized giant unilamellar vesicles (GUVs) [56, 115].
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Previous studies of streptavidin ordering on GUVs demonstrate that streptavidin-coated
GUVs can deform into football-like prolate shapes when the streptavidin protein domains
are aligned and form a continuous envelope (Figure 4-1) [115]. Micropipet aspiration of
streptavidin-coated GUVs shows that the protein-coated bilayer plastically deforms and
GUVs crumple as they deflate [56]. However, the physical mechanisms for how the
streptavidin domains align and determine membrane shape have not been systematically
explored.
Figure 4-1. DIC micrographs of GUVs coated with streptavidin with
spherical (left) and spheroidal (right) morphology. 10 pm scale bars.
We investigate the relationship between the configuration of crystalline
streptavidin domains and vesicle morphology. The streptavidin-coated membrane system
contrasts clathrin-coated membranes, because rather than inducing curvature, we find that
streptavidin domains flatten membranes and resist membrane bending. We develop a
simple model based on domain growth and jamming to account for the shape
transformations of the GUVs. We osmotically stress streptavidin-coated GUVs to study
how protein-coated bilayers respond to deflation and to qualitatively examine how rigid
protein domains influence GUV morphology and stability.
4.2 Materials and Methods
GUVs are prepared by the electroformation method [116] described in Chapter 2
from a mixture of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC, Avanti Polar
Lipids) and N-((6-(biotinoyl)amino)hexanoyl)- 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt (biotin-X-DPPE, Invitrogen). Lipid
mixtures are 10:1 lipid weight ratio (SOPC/biotin-X-DPPE) by mass dissolved in
chloroform (HPLC grade, Mallinckrodt) [56, 115]. We add 0.1 mol % of TR-DPPE to the
lipid mixture to label lipid bilayers for confocal fluorescence microscopy experiments.
GUVs are formed in 608 mOsm glucose solution and suspended in sucrose in order to
provide optical and density contrast [117]. To osmotically stress the GUVs, we suspend
glucose-filled GUVs in hyperosmotic sucrose solutions. In order to achieve higher
osmotic stress gradients, we also form vesicles in 300 mOsm glucose.
Electroformed GUVs are incubated in 20 ýpg/mL protein solution for at least 3 h
to allow crystals to grow and equilibrate on the bilayer surface. Protein solutions are
prepared containing streptavidin (Invitrogen), egg white avidin (Sigma-Aldrich) and
Alexa488-avidin (Invitrogen) dissolved in glucose solutions of the same osmolarity as
those we use to form GUVs. The pH of the GUV and protein solution is adjusted from
pH 5.3 to pH 6 using a 500 mM Tris base solution. GUVs are imaged within 12 h of
synthesis, but remain stable up to 48 h.
Differential interference contrast (DIC) and fluorescence microscopy images are
obtained with 40x and 100x objectives. Glucose-filled vesicles are diluted 5-fold with
660 mOsm sucrose for microscopy. To measure size distributions of the GUVs, we
analyze DIC micrographs using ImageJ software. GUVs are classified as either spherical
or spheroidal; spheroidal GUVs have an aspect ratio greater than 1.1. We determine the
minimum curvature of the spheroidal GUVs by fitting a circle to the major vesicle
curvature.
To study the retention of solutes within the membrane, GUVs are formed in a
glucose solution containing fluorescently-labeled dyes. Either 10 Pg/mL of 10,000MW
Texas Red-Dextran or 100pg/mL of flourescein sodium salt (both Invitrogen) are added
to the sugar swelling solution. GUVs are diluted in sucrose 10-20 fold for fluorescence
microscopy visualization of the concentrated dye inside the vesicles to indicate whether
GUVs leak or rupture.
4.3 Results and Discussion
4.3.1 Shape Transformation
When streptavidin binds to a GUV containing biotinylated lipid, it interacts with
neighboring streptavidin proteins to form two-dimensional crystalline protein arrays on
the surface of the GUV [115]. When the streptavidin crystals are aligned, GUVs exhibit
spheroidal morphology (Figure 4-2). We visualize the streptavidin crystal morphologies
on the surface of fluorescently-labeled GUVs by incubating them in a 10:1 wt ratio of
streptavidin and Alexa488-Avidin. Avidin binds biotin with an affinity near that of
streptavidin but does not crystallize. The fluorescent avidin provides a bright background
to visualize streptavidin domains on the GUV surface approximately 5 gm in length.
When streptavidin domains are randomly oriented (Figure 4-2, left), GUVs have a
spherical morphology. When streptavidin domains align approximately parallel and span
the length of the GUV (Figure 4-2, right), GUVs have football-like shapes which we
approximate as prolate spheroid.
Figure 4-2. Confocal fluorescence micrographs of protein-coated
GUVs incubated in 90 wt % streptavidin and 10 wt % Alexa488-
avidin solution. Fluorescently-labeled avidin (green) is used to
visualize crystalline streptavidin domains on (red) fluorescently-
labeled bilayer. (Left): spherical GUV and (right): spheroidal-shaped
GUVs with aligned streptavidin crystalline domains. Scale bars are 10
glm.
Viewing the protein-coated membrane as a composite material, we can
qualitatively understand how protein domain alignment influences GUV curvature. If the
crystalline domains are a rigid, continuous material, then bending along the major axis of
the spheroidal GUVs is similar to bending parallel beams. This physical model is
supported by the observation that curvatures along the major axes of the spheroidal
GUVs in Figure 4-2, where streptavidin protein domains are aligned, are lower than the
curvatures of spherical GUVs. Along the minor axis of the spheroidal GUVs, however,
there is not continuous rigid crystalline material, but rather defects between crystalline
domains where we expect the membrane to bend more easily. The preference of
streptavidin crystals to grow in a planar fashion is consistent with the previous
observation of large streptavidin crystals that readily grow up to 100 ptm in size on flat
bilayer and monolayer surfaces [62].
4.3.2 Size Trend
An additional observation from Figure 4-2 is that the spherical GUV (left) is
larger in size than the spheroidal GUVs (right). We verify and quantify this trend through
analysis of the size and geometry of a population of 250 GUVs coated only with
streptavidin and imaged with DIC microscopy. Spheroidal GUVs are defined by having
an aspect ratio greater than 1.1. We plot the percent of spheroidal and spherical GUVs at
each diameter in Figure 4-3 to show that smaller GUVs tend to have spheroidal
morphology while larger GUVs tend to have spherical morphology. We define the
diameter of the spheroidal GUVs as the length of the major axis. Although spheroidal
GUVs are observed with a range of sizes, their proportions remain approximately
constant with aspect ratio defined as the length of the major axis over the length of the
minor axis of 1.18 ± 0.08. This suggests that the curvature of the surface on which the
streptavidin crystals grow influences the preferred curvature of the crystals that are
formed. Smaller GUVs have higher curvature than larger GUVs; thus, streptavidin
crystals growing on smaller GUVs must conform to a higher membrane curvature than
crystals grown on larger GUVs or planar bilayers.
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Figure 4-3. Normalized size distributions of spherical and spheroidal
GUVs. Spheroidal GUVs tend to be smaller in size than the spherical
GUVs. The GUV diameter of the spheroidal GUVs is defined as
length of the major axis. Error estimated from binomial distribution
statistics from N=250 GUV micrographs analyzed.
We propose a crystal growth and jamming model to account for the observation
that spheroidal GUVs tend to be smaller. We assume that the number of nucleation sites
per unit area is constant for all lipid bilayer surfaces, as illustrated by the schematic in
Figure 4-4 (left) showing the early nucleation of protein domains on both a large and
small GUV at time tl. At a later time t2 the protein domains have grown and begin to
contact adjacent domains. We define jamming as the state at which protein domains are
in contact with one another and are no longer able to grow. For simplicity, we assume
that for a given GUV, the growth rate of the domains is the same on all surfaces of that
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GUV. If the protein domains have random orientations as they begin to grow, then the
probability of having aligned domains is increased on the smaller GUVs because there
are fewer protein domains. In other words, the fractional probability of N objects with
random orientations on a grid of size N having the same orientation scales exponentially
as -N; therefore, smaller grids, or smaller GUVs with fewer protein domains, have a
higher probability of alignment. The basis for these assumptions is confirmed by
fluorescence and DIC micrographs in Figure 4-4, which demonstrate that larger GUVs
have more domains than smaller GUVs and that the length of the streptavidin domains
does not depend on the size of the GUV on which they grow.
2
Figure 4-4. Model for crystalline domain growth and size trend.
(Left): Illustration of domains at early (tl) and late (t2) time scales.
(Middle and right): Fluorescence and DIC micrographs of GUVs
incubated in 90 wt % streptavidin and 10 wt % Alexa488-avidin
protein solution. Spherical GUVs (middle) are larger and have more
randomly-oriented domains than spheroidal GUVs (right), which have
aligned domains. All scale bars are 10 plm.
To verify the consistency of this physical picture, we estimate the time scales for
the protein domains to grow and diffuse. Streptavidin crystals have a preferred growth
direction on biotinylated GUVs, with C222 crystal lattice structure [62]. The rate of
streptavidin domain growth along the preferred growth direction measured on
monolayers is 1-50 jim/min [64]. We take the lower value of 1 jim/min because our low
ionic strength solution conditions should slow protein crystalline growth [62]. Based on
this growth rate, crystals reach their 5 gm length within 5 min. We compare this time
scale to the approximate time scale for the protein domains to rotate in the membrane.
The rotational diffusion, DR, of a molecule of length E rotating in a membrane with
viscosity p can be calculated from the equation
kT
DR = B• (4-1),
where kB is Boltzmann's constant and T is temperature. We calculate the membrane
viscosity, P =9x 10-2 Pa-s, using the Stokes-Einstein equation and the estimated diffusivity
of monomolecular streptavidin [64], Dr=5x 10-9 cm 2/s. We can use this to calculate the
rotational diffusion coefficient DR and the characteristic time scale for domain rotation
[118], tR~I/DR, over a range of streptavidin domain sizes. We find that tR -0.5 s when
domains are 0.1 jm in size and we estimate tR-70 min when domains are 2 jim in size.
Comparison of the rotational diffusion time scales with our estimated time scale for
crystal growth indicates that the domains grow much faster than they rotate. As the
domains grow quickly on the GUV surface, they are not free to rotate and they approach
a jammed configuration.
4.3.3 Effect of Streptavidin/Avidin Ratio on Vesicle Shape
Transformation
An important consideration in understanding how the arrangement of jammed
streptavidin domains on the GUV surface influences vesicle shape is the surface coverage
of crystalline streptavidin. By adjusting the relative amounts of avidin and streptavidin in
the protein incubation solution, we can control the surface coverage of crystalline
streptavidin relative to non-crystalline avidin. The fraction of GUVs transformed into a
spheroidal shape increases as the concentration of streptavidin in the protein solution
increases, as shown in Figure 4-5. The minimum amount of streptavidin in the protein
solution required to observe spheroidal GUVs is 74-78 mol % streptavidin. Micrographs
(Figure 4-5, b-d) illustrate that the surface coverage of streptavidin crystals increases as
the concentration of streptavidin in the GUV incubation solution increases. The
approximate amount of streptavidin required to observe microscopic crystals with optical
microscopy is 25 mol % streptavidin (Figure 4-5, b). This minimum concentration
threshold is comparable to streptavidin crystallization threshold observed on monolayers
[64] of 15 mol %.
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Figure 4-5. Graph of measured relationship between the fraction of
GUVs observed with spheroidal morphology and amount of
streptavidin used to coat GUVs. Error estimated from binomial
distribution statistics of N=411 micrographs analyzed. Fluorescence
micrographs of protein-coated GUVs with varied concentrations of
streptavidin: (a) 20 mol %, (b) 25 mol %, (c) 29 mol % and (d) 90 mol
%. The remaining protein incubation solution contains 10 mol %
Alexa488-avidin and the balance egg white avidin. (a): No microscopic
protein domains are observed on GUVs. All scale bars are 10 lam.
Consideration of the geometry and coverage of protein crystals near the sphere-to-
spheroid shape transformation threshold allows us to qualitatively describe the
mechanism for spheroidal GUV formation. We observe that spheroidal GUVs require an
aligned continuous network of crystalline streptavidin domains along their major axes,
which requires a minimum coverage of streptavidin. Therefore, we qualitatively describe
the onset of the sphere-to-spheroid GUV shape transformation as an aligned percolation
process, where microscopic streptavidin domains are the percolating material. Once
protein domain coverage enables the formation a continuous network spanning the GUV
length, a percolation threshold is reached and the percolated protein network can deform
GUVs into a spheroidal geometry. In our system, we observe spheroidal GUVs beginning
at streptavidin concentrations of -75 mol %; fluorescent micrographs suggest that below
this streptavidin concentration, the coverage of protein crystals is insufficient to form a
continuous material spanning the membrane dimension (Figure 4-5, b and c). At
streptavidin concentrations above the shape transition threshold, we observe an
approximately linear dependence of the amount of shape-transformed GUVs on the
concentration of streptavidin in the protein incubation solution (Figure 4-5).
Our observations are qualitatively similar to other studies of two-dimensional
percolation of objects with elongated geometry. Studies of randomly-oriented sticks and
their two-dimensional percolation in an aligned direction as a function of stick
concentration and stick alignment show a similar trend, where the probability of
percolation increases approximately linearly as the concentration of sticks increases
[119]. We estimate the surface coverage of streptavidin crystals at percolation using
results for 2-D randomly-oriented overlapping ellipses. If we approximate the
streptavidin crystalline domains as ellipses with aspect ratio of 2-3, then the approximate
coverage of the ellipsoidal domains in a 2D system at percolation, p, can be calculated as
1-pC, where p, is the area fraction of the surface not covered with overlapping ellipses.
The formula to estimate p, as a function of the ellipses' aspect ratio b/a is [120]
pc=(1+4y)/(19+4y) and y=b/a+a/b. We estimate the net area covered by overlapping
ellipses, or the streptavidin crystalline domains, at the percolation threshold to be 0.56-
0.62. In our system, the approximate fraction of the GUV surface covered by streptavidin
domains when GUVs are coated with 90 mol % streptavidin is -0.5. This measurement is
only an approximation, as we are limited by using 2D images to approximate a 3D
surface; however, it suggests that the coverage of streptavidin domains when GUVs
incubate in a solution containing 90 mol % streptavidin is sufficient to span the surface of
the GUVs and thus enable observation of spheroidal GUVs.
4.3.4 Osmotic Stress Response of GUVs
Osmotically stressing our protein-coated vesicles allows us to more thoroughly
investigate how the streptavidin domains resist bending and determine the GUV shape
and stability. Osmotic deflation of lipid bilayer vesicles can be used to characterize
membrane topology [121] and vesicle shape transformations [122]. We osmotically
deflate the glucose-filled GUVs by placing them in a concentrated sucrose medium; the
resulting hyperosmotic environment causes the vesicles to lose part of their internal water
volume to equilibrate the osmolarity of the external and internal solutions [123].
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Streptavidin-coated GUVs viewed in a hyperosmotic sugar environment have two distinct
morphologies: roughened spherical or spheroidal, with a ridge along the vesicle major
axis [115]. Interestingly, under increasing osmotic stress spheroidal GUVs maintain their
major axes and proportions. Figure 4-6 shows the measured curvatures of different
populations of spheroidal GUVs subjected to osmotic stress gradients AOsm=50-400
mOsm (Figure 4-6). Though we vary the osmotic gradient used to stress the GUVs, the
ratio of major curvature to GUV diameter remains approximately constant. DIC
micrographs illustrate how the spheroidal GUVs maintain their morphology even under
high osmotic stress (Figure 4-6, a-d).
o AH=50mOsm
+ AF-=1l00mOsm
* Arl=200mOsm
x An=300mOsm
o AI-=400mOsm
o
24
221
E 20
S18
S16
- 14
o
=12
S10
"• 8
6
A
5 10 15 20
Diameter of GUV [pm]
Figure 4-6. Spheroidal GUVs maintain their shape under osmotic
stress. (Above): Minimum curvature of spheroidal GUVs at different
osmotic stress gradients for N=68 GUVs. The ratio of the minimum
curvature to the GUV diameter is approximately constant. (Below):
DIC micrographs of streptavidin-coated GUVs deflated with osmotic
stress gradients of (a) AOsm=100 mOsm, (b) 200 mOsm, (c) 300 mOsm
and (d) 400 mOsm. Scale bars are 10 g&m.
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We compare the osmotic stress responses of bare GUVs and GUVs coated with
crystalline vs. non-crystalline protein to examine how ordered protein domains affect the
bending properties of the lipid bilayer. Bare, streptavidin/avidin and avidin-coated GUVs
remain spherical when they are not osmotically stressed (Figure 4-7, left column).
Streptavidin domains, however, slightly deform the membrane even in the absence of
osmotic stress (Figure 4-7, b, left column). Upon application of an osmotic stress, bare,
uncoated vesicles can produce internal daughter vesicles (Figure 4-7, i) and become
flaccid (Figure 4-7, ii). These shape and topological transformations resulting from the
decrease in vesicle volume have been observed [121-125] and characterized in terms of
the bending energy and mechanics of lipid bilayers [126]. Crystalline protein domains
prevent the shape and topological transformations typically observed for lipid bilayers.
GUVs coated with streptavidin have a wrinkled morphology upon osmotic stressing and
shrink anisotropically (Figure 4-7, b, right column). Osmotically-deflated spherical
GUVs have a wrinkled appearance with many facets (Figure 4-7, iii). In contrast,
spheroidal GUVs maintain their major axes under osmotic stress (Figure 4-7, iv).
Comparing crystalline and non-crystalline protein coatings further reveals the impact of
the crystalline domains on the osmotic deflation response of the GUVs. When coated
with a mixture of avidin and streptavidin, osmotically-stressed GUVs have a wrinkled
morphology similar to GUVs incubated in only streptavidin (Figure 4-7, c, right column).
This contrasts the behavior the avidin-coated vesicles (Figure 4-7, d), which maintain a
smooth, spherical morphology when stressed but resist budding of the formation of
daughter vesicles. Avidin-coated vesicles often rupture even in the absence of osmotic
stress gradients and few GUVs are present at osmotic gradients above AOsm=250 mOsm.
This effect may be due to the affinity of the avidin-coated GUVs for the glass surfaces
that has been previously observed [56].
no stress osmotic stress
Figure 4-7. DIC micrographs of GUVs with and without applied
osmotic stress. (a): Bare GUVs unstressed (left column) and with
AOsm=250 mOsm osmotic stress (right column). Bare osmotically-
stressed GUVs produce daughter vesicles (i) or become flaccid (ii). (b):
GUVs coated with streptavidin unstressed (left) and osmotically
stressed (right) with roughened spherical geometry at AOsm=250
mOsm (iii) and spheroidal geometry at AOsm=200 mOsm (iv). (c):
GUV incubated in 50 wt % streptavidin/50 wt % avidin protein
solution unstressed (left) and with AOsm=250 mOsm (right). (d): GUV
incubated in avidin protein solution unstressed (left) and with
AOsm=250 mOsm (right). Scale bars are 10 jtm.
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We visualize the wrinkles and facets of osmotically-stressed streptavidin-coated
vesicles in more detail with confocal fluorescence microscopy and fluorescently-labeled
lipid in Figure 4-8. Equatorial micrographs of spherical GUVs (Figure 4-8, a-c) illustrate
the wrinkled or folded regions of the fluorescently-labeled lipid bilayer that form when
the protein-coated membrane is deflated by osmotic stress. Folded features become
deeper and have higher local curvature as the concentration gradient is increased.
Spheroidal GUVs exhibit concentrated lipid folding along their major axes (Figure 4-8,
d). The lipid fold in Figure 4-8, d penetrates the GUV to a depth of approximately 33% of
the total depth of the spheroidal GUV. This confirms our expectation that the membrane
should yield along the defects between streptavidin crystalline domains, which are at a
higher density in this minor axis direction.
Figure 4-8. Confocal fluorescence micrographs of streptavidin-coated
GUVs labeled with 0.1 mol % TR-DPPE subjected to osmotic stress
gradients. (a-c): Equatorial sections of GUVs at (a) AOsm=100 mOsm,
(b) 200 mOsm and (c) 300 mOsm, illustrating the highly curved
wrinkles in the vesicle lipid bilayer. (d): Equatorial section (left) and
projection image (right) of a GUV with AOsm=200 mOsm. The
equatorial image is taken at a depth of 2.5 pm into the GUV with
approximate dimensions 14 pm x 12 pm, length x z-depth. The fold
extends 4 pm into GUV. Scale bars are 10 gm.
Osmotic deflation experiments also allow us to investigate how protein coatings
on lipid bilayers influence topological membrane transformations such as budding. Our
microscopy data suggest that the overall surface area of the protein-coated membrane is
conserved despite osmotic deflation and that membrane budding at high osmotic stress is
suppressed by the streptavidin crystals. In contrast, proteins with high intrinsic curvature
that coat lipid membranes can assist in membrane budding [19, 22]. Clathrin protein
assembles in pits that form detaching buds for cell endocytosis. The lattice formed by the
clathrin proteins is highly curved and this protein curvature determines the size of the
budded internal vesicles that are formed [24, 25]. Our osmotic deflation experiments
suggest that tethered protein domains on lipid membranes with intrinsic curvature lower
than the membrane curvature can prevent membrane budding and locally increase
membrane rigidity. A third category of disordered protein coatings is avidin, which we
show prevents budding under moderate osmotic stress of AOsm=250 mOsm (Figure 4-7,
d, right column). The mechanism of how non-crystalline avidin suppresses budding is
unclear. The general question of how disordered protein coatings affect lipid curvature is
important in cells, however, as diverse protein species reside in the membrane.
Osmotically-stressed streptavidin-coated vesicles present a crumpled shape, with
small regions of very high membrane curvature that may be expected to affect the
integrity of the lipid bilayer. To investigate this, we study the retention of a small
molecule chromophore encapsulated in the vesicles. The retention or leakage of an
encapsulated dye indicates whether the bilayer is porous, ruptured or torn. Figure
demonstrates how the protein-coated lipid bilayer resists rupture and leakage under
osmotic stress. The retention of fluorescein sodium salt (hydrodynamic radius R-~0.5
nm) within the vesicles coated with protein (Figure 4-9, a-c) indicate that no nanometer-
sized holes form in the bilayer even under significant osmotic stress of AOsm=500 mOsm
(Figure 4-9, c). Even after 12 h, the protein-coated GUVs retain the dye with no leakage
measured by fluorescence. Bare vesicles (Figure 4-9, d and e) retain the dye and resist
rupture upon osmotic stressing of AOsm= 250 mOsm (Figure 4-9, e). Interestingly, at
osmotic stress gradients greater than 300 mOsm, no bare GUVs remain in the sample due
to membrane collapse and rupture. We verify this effect in experiments with GUVs
containing fluorescently-labeled lipid subjected to osmotic stress gradients. The stability
of protein-coated GUVs compared to bare unstable GUVs at AOsm=500 mOsm indicates
that the crystalline protein layer protects the membrane. Crystalline proteins on bilayers
in nature may protect primitive organisms. S-layers on the surface of archea and bacteria
are crystalline protein coatings that are linked to the plasma membrane [30]. A possible
function attributed to S-layers is protection of the archea. Our findings are consistent with
previous studies suggesting that S-layers stabilize model membranes subjected to
mechanical stress [55].
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Figure 4-9. Fluorescence micrographs of GUVs encapsulating
fluorescein. Top row: GUVs incubated in streptavidin protein
solution. Bottom: GUVs lacking protein coating. No bare GUVs are
observed at AOsm=500 mOsm. Scale bars are 10 gm.
We also study the retention and leakage of 10,000 MW Texas Red-Dextran,
which has a hydrodynamic radius (Rh) of -2 nm and is therefore approximately four
times larger than fluorescein (Rh -0.5 nm). We observe, however, after diluting the
Dextran-filled GUVs and coating them with streptavidin, that excess Dextran adsorbs to
the streptavidin layer on the outside of the GUVs. The adsorbing effect is seen in
fluorescence micrographs after 12 h under osmotic stress in Figure 4-10. The adsorption
of Dextran to the streptavidin coating prevents us from determining if Dextran remains
inside of the GUVs or leaks from the GUVs. Because Dextran is larger than fluorescein
n s
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and would require larger tears or holes to leak from the GUVs, we do not expect leakage
of Dextran from osmotically-stressed GUVs. Interestingly, without the streptavidin
coating and this adsorption effect, we observe that Dextran has a stabilizing effect on
bare membranes. Uncoated GUVs filled with Dextran resist rupture up to osmotic stress
gradients of AOsm=500 mOsm (Figure 4-10, bottom, right), indicating that the Dextran-
filled GUVs are more stable than bare GUVs, which rupture at AOsm= 300 mOsm.
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Figure 4-10. Fluorescence micrographs of GUVs encapsulating
10,000MW Texas Red-Dextran. Top row: GUVs incubated in
streptavidin solution; Dextran adsorbs to streptavidin coating,
Bottom: GUVs without protein coating; Dextran stablizes GUVs at
AOsm=500 mOsm (bottom, right). Scale bars are 10 gm.
4.4 Conclusions
Understanding the physical mechanism of the assembly and ordering of proteins
on the lipid bilayer and their effect on the membrane curvature gives insight into the
biophysical processes of membrane bending and cell shape changes. Our system of
streptavidin crystallized on GUVs containing biotinylated lipid illustrates how a coating
of ordered protein domains can change the physical properties of the membrane. We
demonstrate that the configuration of the proteins on the lipid membrane surface
determines the shape of the GUVs, as aligned domains resist bending preferentially in
one direction. This model biological membrane system provides an interesting
experimental platform for studying the physical phenomena of two-dimensional
percolation and jamming. We also demonstrate that crystalline protein domains on the
GUV surface prevent vesicle budding and protect the lipid bilayer from rupture or
leakage upon osmotic deflation. Our findings suggest that proteins on cellular membranes
play an important role in cell shape determination and membrane stabilization.
CHAPTER 5. PROTEIN ORDERING
ON SUPPORTED LIPID BILAYERS
5.1 Introduction
Self-assembled protein complexes in cell membranes have diverse functions,
including structural membrane deformation [19, 20] and transduction of external signals
[21]. These complexes can be peripherally attached to the membrane or imbedded in the
lipid bilayer; the nature of this physical arrangement can impact overall membrane
structure and fluidity. An important biological function attributed to membrane-
associated proteins and protein complexes is to directly influence the membrane structure
and fluidity through lipid bilayer modification or rearrangement. To better understand the
biological activity of proteins in cell membranes, it is therefore essential to study proteins
interacting with lipid membranes.
Microscopic and nanoscopic structural studies of protein complexes at membrane
surfaces of lipid membranes offer complementary insight into protein-lipid interactions.
Fluorescence microscopy can be used to measure the mobility of lipids and demonstrates
that proteins bound to lipid bilayers can moderate lipid fluidity [18]. Lipid mobility
likewise influences protein complex formation; microscopy investigation of the growth of
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two-dimensional crystals of the tetrameric protein streptavidin suggests that immobile
lipids hinder formation of protein crystals [61]. At the nanoscale, measurement
techniques employing X-ray and neutron sources provide detailed structural information
that can elucidate the role of proteins in the modification and rearrangement of biological
interfaces. For example, reflectivity measurements reveal that the membrane-targeting
domain of the peripheral protein cPLA-cC2 displaces water molecules around lipid
headgroups to facilitate membrane attachment and ligand binding [60]. Other studies
show that single layers of crystalline protein intercalate lipids, resulting in lipid
headgroup rearrangement [58, 59, 127]. In these X-ray and neutron reflectivity examples,
monolayers provide the model interface for studying surface proteins.
Experimental accessibility traditionally guides the choice of biomimetic lipid
interface used to study protein-lipid interactions at micro- and nanoscales. While
monolayers at the air/water interface are the most common biomimetic interface used for
X-ray and neutron reflectivity studies, they are not as representative of cell membranes as
a single lipid bilayer in the liquid phase. Stacks of multilamellar lipid membranes mimic
the fluidity of cellular membranes and provide signal amplification for X-ray analysis
[128]; however, the stacked geometry complicates study of membrane surface-associated
protein complexes. The base structure for all cell membranes is a single lipid bilayer,
often mechanically coupled to a cytoskeletal matrix, which can be approximated
experimentally by a supported lipid bilayer (SLB) [36]. Reflectivity characterization of a
single SLB requires a sufficiently flat substrate, optimized contrast and minimal beam
damage. Neutron reflectivity offers the advantage of high contrast and little beam
damage; however, X-ray reflectivity at lipid interfaces offers superior resolution [38]. We
extend recent developments to resolve single SLBs with X-ray reflectivity [37, 38, 68,
129] to study the more complex system of proteins interacting with single SLBs at both
microscopic and nanoscopic scales.
We study the proteins streptavidin and avidin bound to biotinylated lipids to
model peripheral membrane proteins at cell membranes. We prepare large (-cm2)
symmetric biotinylated SLBs and study them in a microfluidic device [37] that enables
simultaneous in-situ investigation with X-ray reflectivity and fluorescence microscopy.
Streptavidin forms 2D crystals visualized among fluorescent Alexa488-conjugated
avidin, which binds to the membrane but does not crystallize [61]. By using different
ratios of streptavidin to avidin, we tune the amount of crystalline vs. non-crystalline
protein to examine the influence of protein ordering on the mobility of the underlying
lipid membrane. Previous X-ray and neutron reflectivity characterization of the structure
of streptavidin bound to lipid monolayers [127] allows us to compare bilayer and
monolayer interfaces and, in particular, the structural effect of the protein on the
underlying lipid interface. In addition to structural study, stable SLBs at the solid
interface have potential biosensing and lab-on-a-chip applications, where a single
membrane directly coupled to a surface can be used for measurement and analysis.
5.2 Materials and Methods
We purchase SOPC from Avanti Polar Lipids. The lipids biotin-X-DPPE and TR-
DPPE and the proteins Alexa488-avidin, streptavidin and egg white avidin are obtained
from Invitrogen (Karlsruhe, Germany). We purchase from phosphate buffered saline
(0.01 M PBS; pH=7.4; 138 mM NaC1, 2.7 mM KC1, 10 mM Na 2HPO 4, 2 mM KH 2PO4)
from Sigma. We prepare the buffer in de-ionized (DI) water from Millipore Corp.
(Billerica, MA). HPLC-grade chloroform, acetone, isopropanol and ethanol are from Carl
Roth (Karlsruhe, Germany). We purchase reagent-grade NH40H, 37% HCI and H20 2
from Sigma.
Silicon substrates are cleaned as described in Chapter 2. We prepare the lipid
mixture 89.5 mol % SOPC, 10 mol % biotin-X-DPPE and 0.5 mol % TR-DPPE in
chloroform. We evaporate the chloroform and re-dissolve it in isopropanol for spin-
coating. We spin-coat the lipids onto the substrate, dry the film, secure the substrate into
a microfluidic device and hydrate the SLB according to our protocol outlined in Chapter
2. We rinse the SLBs in microfluidic chambers five times with PBS buffer, then pipette 1
mL of protein solution in PBS at concentration 40 jig/mL into channels to allow protein
layers to form on the SLBs. The SLBs are left undisturbed to incubate in protein
mixtures at least 12 h at 300 C. After forming the protein layer, the chambers are rinsed
out to remove excess proteins.
Both fluorescence microscopy and X-ray reflectivity measurements are performed
at the undulator beamline IDO1 at the European Synchrotron Radiation Facility (ESRF) in
Grenoble, France. The X-ray geometry and setup and the microscope apparatus are
described in Chapter 2.
5.3 Results
5.3.1 Fluorescence Microscopy
After incubating the SLBs in protein and flushing the chambers to remove
proteins in solution, fluorescence microscopy provides direct evidence of protein layer
formation. Dark crystalline streptavidin domains are visualized among fluorescently-
labeled avidin in Figure 5-1. Qualitative observation of the protein crystals in Figure 5-1
gives insight into the overall quality and fluidity of the SLBs. The surface coverage of the
streptavidin clearly increases as the amount of streptavidin in the incubation solution is
increased. Streptavidin crystals in Fig 5-1, II and III exhibit the characteristic X- and H-
shapes of crystals with C222 symmetry observed on monolayers formed in the presence
of bound avidin at similar solution conditions [63, 130, 131]. The nucleation of
microscopic protein crystals requires mobile lipids and a smooth substrate [61] and the
uniform size and random orientations of the streptavidin crystalline domains at each
protein composition suggest that SLBs have uniform fluidity. At low microscopic
resolution (Figure 5-1, left column), the density of the crystals on the SLB is spatially
uniform, suggesting that the nucleation density and crystal domain growth rates are
constant across the SLB.
Crystalline domains at lower streptavidin surface coverages (Figure 5-1, HI and
III) have an average length of- 15 gm and an average length to width aspect ratio of -2.
Characterizing the shapes of the streptavidin domains formed from 90 wt % streptavidin
solution is more difficult, as the domains grow to near confluence (Figure 5-1, I).
Previous experiments in monolayers [131, 132] and bilayers [61] also suggest that high
surface coverage of streptavidin enables dendritic growth of crystals, resulting in
morphologically-indistinguishable domains.
Figure 5-1. Dark crystalline streptavidin domains bound to SLBs
imaged with 10x (left column) and 63x (right column) objectives. SLBs
are incubated in protein mixtures of molar ratios
(streptavidin/avidin/Alexa488-avidin) of (1) 92/0/8, (II) 56/36/9, and
(I1I) 12/78/10. Scale bars are 100 pm in the left column, 10 gLm in the
right column.
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5.3.2 Continuous Bleaching
While the formation of microscopic crystalline domains indicates that our
membranes are fluid, we also quantitatively measure the diffusion constants of lipid
bilayers with and without protein. We use the continuous bleaching method [67, 81],
which is particularly convenient because it employs the same setup we use for
fluorescence microscopy. According to the theory of continuous bleaching, the spatial
intensity of fluorescently-labeled membrane subjected to constant and even illumination
is described by simultaneous photobleaching and replenishment of fluorescent molecules
via two-dimensional diffusion.
We illuminate a defined region of the SLB -180 ptm in diameter (d) at 63x
magnification (Fig 5-2, a, right). This area is continuously illuminated and, as the
fluorescent lipid molecule TR-DPPE is photobleached, the fluorescence intensity, Id/2, Of
the SLB in the center of the illuminated area (d/2), decays exponentially as a function of
exposure time (t) according to the equation:
Id/2 (t )= e- Bo I (5-1).
Iro is the initial fluorescence intensity at the center of the illuminated area, Bo is the
bleaching rate and r is dimensionless time, r = Bot. We calculate I~o from the average
intensity of an area of -10 jtm in diameter in the center of the sample, represented by
circles in the SLB micrographs of Figure 5-2, a. The total fluorescence intensity
measured in the center of the sample, Itotal,d/2, is the sum of Id/2 and the background
fluorescence measured in the non-illuminated part of the membrane, A,, and Itotal,d/2
Id/2 A1 . We calculate Bo, which depends on the fluorescent dye, solution conditions and
illumination energy, by fitting Equation 5-1 to the time-resolved intensity in the center of
the sample for each continuous bleaching measurement. The plot of Id/2 as a function of
time is presented in Figure 5-2, b and the dashed line calculated from Equation 5-1
illustrates that the first-order behavior described by Equation 5-1 persists up to -1000 s.
At longer times, the fluorescence intensity measured at the center of the membrane
approaches the background fluorescence AI, indicating that the center of the membrane is
fully bleached.
As the sample is bleached, a bright rim appears at the edge of the image (Figure
5-2, a, bottom right), as TR-DPPE molecules diffuse into the illuminated area. Once the
center of the sample approaches the background fluorescence and remains constant, at
approximately r > 20, we fit the fluorescence intensity line profile through the sample as
a function of distance, x, according to the equation [81]:
I(x)= I,, cosh( BD(x - d/2))+ A2  (5-2).
The fluorescence intensity at the edge of the rim is Ixo, D is the diffusion constant and A2
is a constant we use to fit Equation 5-2 [81]. Diffusion constants extracted by fitting
Equation 5-2 to the line profiles at 5 s intervals are plotted in Figure 5-2, c. The fit of
Equation 5-2 to a line profile is shown in Figure 5-2, a. According to the original
development of continuous bleaching theory, Equation 5-2 can only be used to accurately
calculate D at longer times, when the center of the sample is completely bleached [81].
This time regime is indicated in Figure 5-2, c and is represented qualitatively by the
plateau of extracted D values at z > 20. For data suitable for robust quantitative analysis,
extra care must be taken to ensure even sample illumination and a flat initial line profile
(Figure 5-2, a) and the center of the sample must be completely bleached to the
background level to calculate the diffusion constant D.
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Figure 5-2. Continuous bleaching of TR-DPPE to measure lipid
diffusion in a SLB coated with protein layer of 92/8 molar ratio
(streptavidin/Alexa488-avidin). (a): Line intensity profiles and
corresponding micrographs at the onset of bleaching (0 s) and end of
the experiment (1900 s). The fit to the line profile at 1900 s from
Equation 5-2 is shown in red. (b): The plot of background-corrected
fluorescence intensity in the center of sample as a function of time is
used to determine the bleaching rate Bo; the dashed line is calculated
from Equation 5-1. (c): Diffusion constant D extracted from fitting
line intensity profiles at 5 s time intervals to Equation 5-2. The longer
time regime (r> 20) is indicated when the center of the sample is fully
bleached and Equation 5-2 is valid for calculating D.
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We reproducibly measure the diffusion constants of our SLBs using the
continuous bleaching method and we investigate whether the protein layer influences the
fluidity of the bilayer. Table 5-1 lists the lipid diffusion constants of the SLBs. We
measure that protein binding to the SLB results in a slight decrease in lipid mobility, as
lipid diffusion constants are reduced -10-15% when a protein layer is present. Neither the
composition of the protein mixture nor the area coverage of crystalline protein has a
measurable effect on lipid mobility. Previous studies of multivalent polymers adsorbed to
lipid bilayers at complete surface coverage also show little effect on measured lipid
diffusion compared to bare bilayers [133]. After bleaching, the SLBs recover to their full
original fluorescence overnight and we are unable to detect an immobile fraction of
lipids.
Composition of protein solution Diffusion constant, D (Apm2/s)
no protein (bare SLB) 2.3 ± 0.4
90 wt % streptavidin, 10 wt % avidin 2.0 + 0.1
50 wt % streptavidin, 50 wt % avidin 1.9 ± 0.1
10 wt % streptavidin, 90 wt % avidin 1.9 ± 0.1
100% avidin 2.0 + 0.1
Table 5-1. Diffusion constants calculated by fitting Eqs. 5-1 and 5-2 to
continuous bleaching data. SLBs are incubated in protein solutions
with compositions listed; total mol % avidin comprises -5 mol %
Alexa488-avidin and the balance egg white avidin. Three different
time-resolved line profiles are measured for every sample, each
corresponding to N > 20 calculations of D. Error is estimated as the
experimental standard deviation.
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We also investigate whether the protein molecules within the protein layers
attached to the SLBs are mobile by using fluorescently-labeled avidin as a tracer
molecule. When we continuously illuminate protein-coated SLBs at 488 nm,
corresponding to the Alexa488-avidin, we do not observe the bright rim at the sample
edge characteristic of a fluid membrane. Instead, the illuminated area, viewed at 10x after
1 h of bleaching and shown in Figure 5-3, has a sharp outline and a flat fluorescence
intensity profile, indicating no diffusion of the Alexa488-avidin. Note that due to the high
photostability of the Alexa dye, there is only minimal bleaching of the protein layer. This
immobility is observed at all protein layer compositions and time-resolved images show
that the streptavidin domains remain fixed, further indicating the immobility of the
protein layer.
We expect the diffusion constant of the bound protein to be lower than that of the
underlying lipids, by comparison of the relative molecular sizes of a lipid molecule (-7
A) and a single protein molecule (-50 A) [134]. The molecular size-scaling of the
diffusion constant in a SLB is not accurately described by the hydrodynamic model of
diffusion [ 118] that we use to describe protein complexes in fluid lipid bilayer vesicles
[135] due to frictional contact between the lipids and the solid substrate [136]. Due to the
bivalent attachment of the protein molecules to the lipids, each protein molecule must
diffuse with two lipid molecules separated by a fixed distance; as multivalent streptavidin
crystalline complexes form, an increased number of bound lipids must diffuse with fixed
spacing. The mobility of the non-crystalline protein molecules can also hindered by
collisions with adjacent proteins at our experimental condition of high protein surface
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coverage. Previous observations show that proteins attached to membranes at high
surface coverages can diffuse 20-100 times slower than lipids [131]. We can therefore
expect the streptavidin and avidin to be fixed and immobilized relative to the underlying
lipids not attached to the protein at our experimental conditions of high protein surface
coverage.
Figure 5-3. After continuous fluorescence illumination of SLB coated
with 92 mol % avidin, 8 mol % Alexa488-avidin at 488 nm for 1 h, no
diffusion of Alexa488-avidin is detected. The bleached region is clearly
outlined (left) and the line intensity profile indicates uniform
fluorescence across the bleached region. Scale bar is 100 pm.
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5.3.3 X-ray Reflectivity
X-Ray reflectivity enables us to determine the structure of the protein and
underlying bilayer in nanoscopic detail. In Figure 5-4, we compare the reflectivity of bare
and protein-coated membranes. The main signature of the protein layers in Figure 5-4, I-
III is the dip in the reflectivity curve at q, = 0.1 A', indicating an additional layer on the
lipid bilayer membrane, which is not present in scans of the bare membrane (Figure 5-4,
IV). From initial observation, the reflectivity scans from the different protein layer
compositions shown in Figure 5-4, 1-I11 are nearly indistinguishable. The similar
reflectivity from different ratios of avidin and streptavidin are not surprising, as avidin
and streptavidin have similar structures [137]; 33% of the residues are the same [65] and
their biotin-binding sites are nearly identical. This structural similarity, combined with
the fact that our reflectivity scans are measured with an incident beam on the membrane
of size - 1 mm2, make avidin and streptavidin indistinguishable by our measurements.
Thus, our X-ray reflectivity fits do not take into account the segregation of the proteins
once crystals are formed.
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Figure 5-4. Normalized reflectivity scans of protein-coated (I-III) and
bare (IV) SLBs. Protein-coated SLBs (I-IIl) have a signature dip at qz
= 0.1 A-'. SLBs coated with protein mixtures with molar ratios
(streptavidin/avidin/Alexa488-avidin) of (I, blue) 92/0/8, (II, green)
56/36/9, and (III, red) 12/78/10. The common depth profile is plotted
with the data sets in I-III to illustrate the similarity of the streptavidin
and avidin-protein layers. The reflectivity of a bare SLB lacking
protein (IV) is shown with its fit (orange curve). Plots are shifted
vertically for clarity; all data are background corrected and
normalized by the Fresnel reflectivity, RF.
To extract structural details of the protein layer and underlying SLB, we fit the X-
ray reflectivity data using a least-squares fitting routine. We use an 11 slab model for the
protein-coated SLBs; the thickness and electron density for each slab is varied to fit the
raw data [85]. We model the underlying SLB with 7 slabs: 2 slabs for each headgroup
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layer, one slab for each acyl chain layer and one slab for the space between leaflets. The
region between the bottom of the peripheral protein layer and the upper surface of the
SLB is one slab and we use 3 slabs to model the protein layer. This slab model profile is
smoothed by an overall roughness of 3 A, as described in Chapter 2. We test the
structural similarity of protein-coated SLBs formed from different compositions of
streptavidin and avidin by fitting the data to a single depth profile. The fit to this common
profile is plotted with the data at each protein composition in Figure 5-4, I-IIL.
In Figure 5-5 we present the electron density profiles of protein-coated and bare
SLBs, with a corresponding sketch of the peripherally-bound protein. The common depth
profile of the protein-coated SLB is shown; thus, this profile represents both streptavidin
and avidin in the protein layer (Figure 5-5, black curve). The protein layer attached to the
bilayers is indicated by the characteristic increase in electron density, at distance of 55-95
A from the substrate. In contrast, the electron density profile of the bare SOPC/biotin-X-
DPPE SLB is flat in this region (Figure 5-5, orange curve). We measure a -40 A-thick
protein layer on the SLB. This thickness is comparable to previous X-ray and neutron
reflectivity studies of streptavidin crystallized on monolayers, where thicknesses of 40-44
A [57, 127, 138] are reported, which is near the thickness of avidin measured by X-ray
crystallography of -40 A [137]. Our dynamical range extends up to qmax= 0.6 A-' and the
spatial resolution of the electron density profile, dmin, is estimated by the sampling
theorem as dmi- [129]. According to this relation, our resolution is dmin-5 A. We
q max
are therefore able to resolve the space between the protein and SLB, which is -8 A in
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thickness. This hydrated layer is structurally distinct from the headgroups and protein
because the electron density in this space approaches the bulk water density. To verify
the structural similarity of protein layers with different amounts of avidin and
streptavidin, we also independently fit the scans for each protein composition, allowing
the thickness and density of each slab to vary. As expected, the individual profiles
extracted from the reflectivity of different streptavidin and avidin protein layers are
identical within the precision of our measurements.
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Figure 5-5. Electron density profiles of SLBs with a protein layer
(black, common profile) and without protein (orange) extracted from
fitting the reflectivity. The protein layer is identified by a plateau of
increased electron density not seen on the bare SLB (orange). The
thickness of the protein layer is - 40 A; the water layer separating the
protein from the SLB is - 8 A thick. The electron density axis is
correctly aligned for the protein-coated SLB (black); the profile of the
bare SLB (orange) is shifted left for clarity.
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5.4 Discussion
We create large stable arrays of protein crystals on single supported lipid bilayers
suitable for simultaneous microscopy and reflectivity characterization. Our protein-
coated SLBs remain stable for characterization over 48 h. In developing a biomimetic
interface for studying protein complexes, we require bilayer stability for time-resolved
investigation of biological self-assembly at interfaces. Also, large surface coverage of the
bilayer becomes important, as both reflectivity and microscopy require homogeneous
samples of dimension -100 Am 2. Fluorescence microscopy micrographs (Figure 5-1)
provide direct evidence of protein layer formation and high surface coverage.
Using the complementary insight from our combined microscopic and nanoscopic
characterization of protein-coated membranes we can describe how the protein layer
interacts with the lipid in greater detail. The high resolution that we accomplish with X-
ray reflectivity allows us to examine the structure of a single layer of protein on a SLB.
Since streptavidin and avidin irreversibly bind the headgroups of biotin-X-DPPE lipids
and are immobile relative to the lipid molecules, we expect the lipids bound to the
tethered protein layer to be immobilized. We approximate the number of pinned lipids in
the bilayer by estimating the number of lipid molecules per protein molecule. If the
approximate area per lipid headgroup is 50 A2 and the protein molecules are z 50 x 50 A2
in area, then the footprint of the protein is -50 lipids. Bivalent binding of the protein then
suggests that 4 mol % of the lipids are pinned. The slight decrease in the lipid diffusion
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constants determined by continuous bleaching experiments, where binding of the protein
reduces the diffusion constant of the lipid probe by -10-15%, suggests that pinning of
biotinylated headgroups due to protein layer binding and the presence of a solid protein
layer above the membrane can influence membrane fluidity.
Despite the immobilization of the biotinylated lipids, the SLB is fluid and is
viscously decoupled from the protein layer. We attribute this to the space between the
SLB and protein layer that we measure with X-ray reflectivity. The molecular contents of
this layer are water and the portion of the biotin-X-DPPE separating the biotin from the
headgroup. The main protein-lipid interaction that we resolve in our structural study of
streptavidin and avidin binding to SLBs is therefore immobilization of biotinylated lipids
bound to protein. These observations contrast the effects observed upon streptavidin layer
formation on monolayers at the air/water interface. The lipids show major tilting, and
rearrangement, resulting in overall reduced monolayer thickness [127]. Stable lipid
bilayers resist leaflet collapse and, unlike lipid monolayers, cannot easily adjust surface
pressure and density in response to ligand binding. We suggest that lipid bilayers are
more representative of cell membranes and more appropriate for studying protein-lipid
interactions than monolayers, as we expect the lipid spacing in cells to also be somewhat
fixed.
Interestingly, the fluidity and structure of lipid bilayers with non-crystalline
avidin and microscopic crystalline streptavidin domains are similar. Both protein coatings
are qualitatively immobile or frozen and cause the same slight decrease in the fluidity of
the underlying lipids. While we would expect non-crystalline avidin to be more mobile
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than streptavidin molecules confined to crystalline domains, in our model of lipid
pinning, all bound protein molecules are immobilized relative to the viscously decoupled
underlying SLB.
5.5 Conclusions
We concomitantly characterize a single protein layer bound to a single SLB with
fluorescence microscopy and X-ray reflectivity. In this protein template, streptavidin and
avidin are specifically bound to a fluid interface with defined orientation, which may be
superior to simple solid-supported protein interfaces for biosensing applications. We
demonstrate a method of characterizing proteins interacting with single lipid bilayers at
the solid interface; this biomimetic membrane is more representative of cell membranes
than monolayers and can be extended to study more complex protein-lipid interaction
systems. By resolving the space separating the streptavidin and avidin layers from the
SLBs, we demonstrate that the lipid-protein interaction is peripheral, contrasting the
leaflet collapse effects observed from similar molecules in lipid monolayers. Our study
suggests that proteins in general can have different effects at monolayers and bilayers.
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CHAPTER 6. GM1 GANGLIOSIDE
AND MODEL LIPID RAFTS IN
SUPPORTED LIPID BILAYERS
6.1 Introduction
The monosialoganglioside receptor GM 1 is the entry point for the protein cholera
toxin at the cell membrane surface. The B subunit of cholera toxin (CTB) binds sugar
oligosaccharide groups of GM1 that extend out from the surface of the membrane [139].
Once CTB is bound, five GM1 molecules per CTB form a pentagonal complex [140] that
allows the toxin to cross the membrane into the cell to induce disease [16]. The lateral
diffusion of GM1 in the membrane and its co-localization with other GM1 molecules to
form the CTB-GM1 complex is therefore a vital step in the delivery of cholera toxin to
cells. A possible mechanism for concentrating GM molecules is the preferential
partitioning of GM 1 into different lipid environments of the cell. CTB entry into the cells
can be facilitated by binding GM 1 receptors concentrated in cell membrane domains that
are enriched in sphingolipids, cholesterol and the protein caveolin-1 [16]. In model
biological membranes, GM1 localizes to liquid-ordered lipid phases [4, 141], though
other studies suggest that GM1 localization to model lipid rafts requires CTB binding [9,
17]. A better understanding of the influence of GMI and the GM1-CTB complex on the
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local lipid packing of the cell membrane could clarify why GM I1 prefers certain lipid
phases.
Surface-sensitive techniques for characterizing lipid interfaces suggest that GM1
can moderate lipid packing. GM1 itself diffuses more slowly than the surrounding lipids
and the mobility of GM1 is further reduced when it binds to CTB [18, 49]; in cells, the
GMI-CTB complex is immobile [142]. Fluorescence microscopy experiments
demonstrate that GMI decreases the mobility of surrounding lipids [143, 144],
particularly if the surrounding lipids are near a gel phase transition [18]. One possible
cause of the reduced mobility of GM 1I imbedded in lipid membranes is GM 1 aggregation,
which is observed in lipid bilayers [145, 146], and is facilitated by CTB binding. GM I in
an aggregated form can then translocate to liquid-ordered lipid phases [9], thus relocating
to a denser lipid environment. Other examples of lipid-bound molecules similarly move
into denser lipid phases upon complexation [7, 8]. Additional possible mechanisms of
lipid fluidity moderation by GMI are disruption of lipid headgroup packing [147] and
lateral condensation of lipid molecules [145].
Improving our understanding of this well-observed effect that GMI is able to
influence lipid fluidity in membranes requires molecular-level structural information. X-
ray and neutron reflectivity studies offer the advantage of nanoscale-resolution insight
into the structure of the membrane. Previous measurements of lipid monolayers with
neutron reflectivity demonstrate how reflectivity can be used to gain structural
information about the GM1-CTB complex interacting with lipids; complex formation
may decrease the lipid density and perturbing lipid packing [147]. We aim to investigate
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whether these lipid packing perturbations observed in monolayer systems persist in more
biologically-relevant bilayers. We also want to compare lipid bilayers containing GM I to
those lacking the receptor to understand how GMl alone may influence lipid packing
before binding CTB. Using the experimental platform of X-ray reflectivity and
fluorescence microscopy of single lipid bilayer membranes [37], we incorporate GM1
asymmetrically into fluid supported lipid bilayers (SLBs). X-ray reflectivity allows us to
verify this asymmetry and to study in detail the lipid packing modification caused by
GM1 insertion. We first present our studies of GMI in homogeneous membranes,
followed by investigation of GM 1 in cholesterol-enriched lipid bilayers.
6.2 Materials and Methods
DOPC, cholesterol, BSM and the ovine brain ganglioside GM1 are purchased
from Avanti Polar Lipids. TR-DPPE and the Alexa Fluor 488-labeled cholera toxin B
subunit (CTB) are purchased from Invitrogen. All lipids are prepared in HPLC-grade
chloroform, except for TR-DPPE and GM1 when dissolved in organic solution, which we
prepare in 1:1 mixtures by volume of chloroform and methanol. We use the extrusion
method described in Chapter 2 to prepare LUVs for experiments. When preparing LUVs
with model lipid raft compositions of cholesterol/BSM/DOPC, we extrude lipids at a
temperature above the lipid phase transition temperature, Tm, using the GUV lipid phase
diagram for these lipid compositions as a reference to determine Tm [148]. The LUVs are
used to form SLBs on SiO2 substrates in microfluidic chambers via vesicle fusion
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assisted by osmotic rupture (Chapter 2). We also use spin-coating technique to form
symmetric SLBs containing GM1. The chloroform/methanol lipid solution is completely
dried, re-dissolved in isopropanol, then applied to substrates with spin-coating as
described in Chapter 2.
Because GM 1 is an amphiphilic molecule, it can spontaneously partition into lipid
vesicles in aqueous solutions [149]. We extend this technique to incorporate GM1 into
pre-formed solid-supported lipid bilayers incubating SLBs for 4 h in solutions of GM 1 in
DI water at a concentration of 1 mg/mL. GM1 in aqueous solutions can aggregate and
form micelles [150]. To investigate if there is a concentration-dependence of GM1 on
SLB structure, we also incubate SLBs with GMl-enriched LUVs for 4 h. We use LUVs
that have the same lipid concentration as the SLBs; to prepare GM -enriched LUVs, we
incubate LUVs with aqueous GM1. As we are unable to determine the partitioning of the
GM1 into the LUVs, we calculate the stoichiometry of the combined LUV and GM1
solution; we use 1, 5 or 20 mol % GM1. We prepared and measured our samples at the
ESRF IDI beamline, with the beam characteristics described in Chapter 5, at two
separate beamtimes to verify the reproducibility of our observations. For X-ray
reflectivity measurements, we use the microfluidic chamber and reflectivity setup
described in Chapter 2.
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6.3 Results and Discussion
6.3.1 GMI in Homogeneous Membranes
We first characterize GMI insertion into a homogeneous fluid lipid bilayer. The
fluid SOPC lipid bilayer provides a well-defined interface for understanding the
structural influence of GM1 on lipid bilayer membranes. The transition temperature of
SOPC is -5 0 C, ensuring that it is at a stable, fluid liquid state at room temperature. We
first examine GM insertion into fluid lipid bilayers of 99.5 mol % SOPC and 0.5 mol %
TR-DPPE with X-ray reflectivity. The reflectivity scan of the SOPC membrane is shown
in Figure 6-1, a. The oscillations are characteristic of a single fluid lipid bilayer above a
solid support [37, 38]. After incubation for 4 h with excess GM1, the membrane changes
significantly. Figure 6-1, b presents the reflectivity scans of the SOPC membrane after
GM1 insertion. The most prominent effect of GMI incorporation into the membrane is a
shift in the positions of the minima. The first minimum shifts from q, - 0.2 to 0.18 A-',
the second from 0.34 to 0.3 A-'. These shifts of the minima to a lower momentum
transfer (qz) qualitatively indicate a thickening of the bilayer.
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Figure 6-1. Reflectivity scans with fits for single SOPC bilayer before
(a) and after (b) incubation with excess GM1. The vertical lines
illustrate the shifts of the minima at qz ~ 0.2 A8' (red) and qz ~ 0.35 Al-(green) after GM1 insertion into the membrane.
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In order to further investigate this bilayer thickening upon GM 1 insertion and to
determine how the leaflet dimensions are changed, we fit the reflectivity scans in Figure
6-1 using a 7 or 9 slab model [85]. To model the SOPC layer without GM1, we follow
the procedure in Chapter 5, where each leaflet has 2 slabs representing the headgroups
and one slab for the acyl chains; the interleaflet space is an additional slab. To account
for the large oligosaccharide headgroup of the GM 1, we use a 9 slab model to fit the
SOPC layer after GM1 insertion, where the headgroup region of GM1 has two additional
slabs. The thicknesses and electron densities of each slab are the only parameters that are
varied in the fitting process, outlined in Chapter 2. The roughness of each slab for
smoothing the overall fit is 3 A. Figure 6-2 shows the electron density profiles extracted
from fitting the reflectivity scans in Figure 6-1 with this model.
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Figure 6-2. Electron density profiles extracted from the reflectivity of
a SLB of SOPC before (green curve) and after (red) GM1
incorporated into the upper leaflet of the membrane.
Near the solid substrate, the electron density profiles in Figure 6-2 are nearly
identical up to a distance of 20 A. This region describes the headgroups and acyl chains
of the lower leaflet of the SLB and the water layer separating the membrane from the
substrate. A thickening of the upper leaflet of the membrane is clearly demonstrated by
the shift of the peak corresponding to the electron-dense headgroup region of the upper
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leaflet, from - 42 to 48 A. Also, the overall electron density of the headgroups in the
upper leaflet increases upon SOPC insertion from 0.45 to 0.5 e/ A3.
The similarity of the profiles from Figure 6-2 of SOPC and SOPC/GMl in the
lower leaflet region of the SLB, contrasting the headgroup repositioning and density
change in the upper leaflet, shows that GM 1I does not affect the electron density of the
lower leaflet. This result suggests that GM inserts only into the upper leaflet of these
supported membranes and does not flip into the bottom leaflet. By repeating our
measurement of the reflectivity of the SOPC/GM1 membranes after 3 days, we verify
that GM1 remains in the upper leaflet, as the reflectivity does not change over this time
scale. By incorporating GM 1I in the upper leaflet of the bilayer, we mimic the orientation
of GMI in cell membranes and we can systematically observe the effect of GM1 on the
structure of a single leaflet coupled to a supported leaflet. This method of inducing
asymmetry in a symmetrical SLB may also be useful for creating layered structures on
SLBs.
We have also used the spin-coating method described in Chapter 2 to prepare
symmetric SLBs containing 1-2 mol % GM1 in both leaflets. Fluorescence microscopy
characterization shows, however, that these SLBs are inhomogeneous, and non-uniform.
This may be due to a repulsive interaction between the negatively-charged sialic acid of
the GM1 headgroup and the SiO 2 substrate. It has been suggested that GMI
asymmetrically distributed in the outer leaflet of lipid bilayers may confer stability to the
overall membrane [151].
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The electron density profiles before and after GM1 insertion are consistent with
protrusion of the GM 1 headgroups above the bilayer surface, which is reported both with
X-ray diffraction [152] and AFM [146]. The hydrophobic tail structure of GM1 is
different than the tail structure of SOPC; both of the chains of SOPC have 18 carbon
atoms, though one chain is unsaturated. The ceramide chains of GM1 are saturated; one
chain is 18 carbons in length and the other chain has 15 carbons. Previous measurements
indicate that GMI can protrude above lipid headgroups at a distance of -12 A [152].
We observe this stretching effect of GM1 on the upper membrane leaflet of SOPC
after incubating the SLBs in excess GMI in solution. We also investigate whether these
structural membrane changes depend on the amount of GM1 available in solution. To
control the amount of GM I we add to SLBs for incubation, we first prepare LUVs of
SOPC enriched in GMI by incubating the LUVs in aqueous GM 1. These GM -enriched
LUVs are then used for incubating the bilayers, thus diluting the concentration of GMI
available to the membrane. In Figure 6-3, b, the reflectivity of an SLB after incubation
with LUVs of composition 99 mol % lipid and 1 mol % GM 1 is presented. There is little
difference between the reflectivity of this scan and that of the SLB incubated in excess
GMI (Figure 6-3, a). The slab model fits to the data are nearly identical and show the
same increase in the headgroup density - 8 A. Since the effect of GM1 insertion is
essentially the same at low and excess GMl concentrations, we believe that GM1
incorporation reaches a saturated concentration at all of the incubation concentrations that
we use.
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When CTB binds five GM1 receptors, the resulting complex becomes the entry
point for the entire cholera toxin protein to cross the membrane [16]. A recent study of
CTB bound to GM 1 in monolayers suggests that the density of the lipid leaflet is slightly
decreased upon CTB binding [147]. To investigate whether this effect is observable in
lipid bilayers, we measure the binding of fluorescently-labeled CTB to SOPC/GM1
membranes. CTB binding to the membrane is evidenced by fluorescence microscopy, as
the membrane after incubation with CTB is bright and non-specific binding of CTB was
not observed in a control experiment. Figure 6-3, c presents the reflectivity of a SLB with
GM1 after incubation in CTB, which is nearly identical to the reflectivity from SLBs
lacking CTB (Figure 6-3, a and b). Unlike the distinct increase in reflectivity that we
observe in SLBs coated with streptavidin and avidin in Chapter. 5, we do not detect the
bound CTB in the reflectivity. Thus, CTB does not provide enough electron density
contrast to be resolved with our measurements. The low electron density contrast of CTB,
compared to our SLBs, may be due to its relatively hollow ring structure and height
above the membrane of -20 A [139]. We also do not detect a modification of membrane
structure upon CTB binding, in contrast to reports of CTB-GM1 interaction in
monolayers [147]. Studying ligand-receptor binding events in lipid bilayers is more
biologically relevant than monolayers; in stable cellular membranes, we do not expect the
lipid spacing to readily adjust to ligand binding. In future experiments, gold-conjugated
CTB or using both the A and B subunits of cholera toxin may enhance the electron
density contrast between CTB and the SLB for measurement with X-ray reflectivity.
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Figure 6-3. Reflectivity of SOPC membranes incubated in GM1 at
excess concentrations (a,c) and in a LUV solution with SOPC/GM1
stoichiometry of 99/1 (b). The SLB in c is measured after incubation
with CTB; there is no detected change in the reflectivity due to CTB
binding GM1.
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6.3.2 Model Lipid Rafts at Solid Interfaces
We expect the effect of GMI on membrane structure in lipid membranes of
cholesterol, brain sphingomyelin (BSM) and DOPC to be more complex than GM1 in
homogeneous SLBs of SOPC because mixtures of cholesterol/BSM/DOPC phase
separate into liquid-disordered and liquid-ordered phases, modeling lipid rafts in cell
membranes [4]. This phase separation is readily observed with fluorescence microscopy
in fluid lipid bilayer vesicles [4, 45]. On solid-supported interfaces, however, lipid
domains lack the reversible phase behavior characteristic of fluid membranes and the
domains can be pinned to the substrate [50].
When we prepare SLBs from cholesterol/BSM/DOPC lipid mixtures on the SiO2
substrates that we use for reflectivity, we do not observe microscopic lipid rafts.
Interestingly, when we use a slightly rougher substrate with a 600-nm thick thermal SiO 2
layer and surface roughness -4-5 A, we observe microscopic domains. Figure 6-4
compares SLBs with the same lipid composition of 20 mol % cholesterol, 40 mol % BSM
and 40 mol % DOPC on a smooth SiO2 substrate of roughness -3 A (Figure 6-4, a) and a
rough SiO2 substrate with roughness -4-5 A (Figure 6-4, b). Only on the rougher SiO 2
substrate are microscopic phases observed: a dark background phase excluding the TR-
DPPE dye, and a bright minority phase with relatively round edges. We confirm the
fluidity of the SLB in Figure 6-4, b by fluorescence bleaching and recovery.
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Figure 6-4. SLBs of 20 mol % cholesterol, 40 mol % BSM and 40 mol
% DOPC deposited SiO 2 substrates with surface roughness of (a) a =
3 A and (b) a = 4-5 A. The thicknesses of the oxide layer are 100 nm in
(a) and 600 nm in (b). Microscopic lipid rafts are only observed on the
rougher substrate (b). Scale bars are 10 pim.
The rougher SiO 2 substrates that support microscopic lipid phases (Figure 6-4, b)
do not produce a high-quality X-ray reflectivity signal. Our X-ray reflectivity
measurement setup requires molecularly flat SiO2 substrates with maximum surface
roughness '3-3.5 A; consequently, all of the model lipid raft lipid mixtures that we
measure with X-ray reflectivity do not have microscopic lipid phases. Our large
incidental X-ray footprint of -1 mm 2 also precludes measurement of discrete and
segregated microscopic phases; thus, our X-ray fitting methods indirectly assume lateral
homogeneity in the membrane. It is possible that our model lipid rafts with homogeneous
fluorescence (Figure 6-4, a) have nanoscopic phases. Lipid phases measured in cells [52,
109] and seen in similar mixtures on flat supported substrates [145, 153] are -10 nm in
size.
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We examine the structure of membranes of cholesterol, BSM and DOPC with
reflectivity prior to GMI incubation. The reflectivity scans of the SLBs from our model
lipid raft mixtures are shown in Figure 6-5. Interestingly, the second minimum of the
reflectivity of the SLB with 30 mol % cholesterol (Figure 6-5, a, II) is not as clearly
defined as the second minima of the membranes with 20 and 40 mol% cholesterol (Figure
6-5, a, I and III). The reflectivity from all of the model lipid raft SLBs have less-defined
second minima compared to the reflectivity of homogeneous SOPC (Figure 6-1, a). Since
the overall quality and resolution of the model raft and SOPC scans are the same, this
smearing effect at the second minima may be due to destructive interference, or
heterogeneous structures in the membrane of different dimension. This may also be an
effect of lipid phase separation, which introduces heterogeneity into the membrane. The
electron density profiles extracted from the fits to the reflectivity are shown in Figure 6-5,
b. The profiles of the cholesterol/BSM/DOPC membranes reveal in more detail the
structure of cholesterol-enriched membranes. The most prominent membrane structural
changes with increasing cholesterol content are (1) a decrease in the electron density of
the lipid headgroups away from the substrate and (2) a concomitant thickening of the
lipid bilayer. These trends are summarized in Table 6-1.
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Figure 6-5. Reflectivity (a) and electron density profiles (b) of SLBs
containing cholesterol, BSM and DOPC with fixed 1:1 BSM/DOPC
molar ratio and cholesterol concentrations of (I, red) 20, (II, green) 30,
and (III, blue) 40 mol %.
127
Lipid composition Thickness of the bilayer Electron density of the headgroup
20 mol % cholesterol 46 A -0.52 e /A
40 mol % BSM
40 mol % DOPC
30 mol % cholesterol 51 A -0.48 e/A 3
35 mol % BSM
35 mol % DOPC
40 mol % cholesterol 56 A -0.43 e/A3
20 mol % BSM
20 mol % DOPC
Table 6-1. Summary parameters from the electron density profiles
extracted from reflectivity fits of SLBs with model lipid rafts
compositions. The overall bilayer thickness and the electron density of
the headgroup of the outer leaflet for each composition are listed.
Our result that cholesterol thickens the bilayer is consistent with previous NMR
studies [154]. Lipid rafts enriched in cholesterol are reportedly thicker than typical
homogeneous membranes by -5 A [153]. An additional feature of these model lipid raft
membranes not observed in SOPC membranes can be seen in the hydrophobic chain
region of the electron density profiles in Figure 6-5, b. The hydrophobic chains appear to
have discrete layers of different electron density, indicated by the step-like feature in the
profiles at a distance of 30-40 A. The feature is also noticeable in the lipid chain region
near the interface. This may be due to cholesterol arranging in a layer near the lipid
headgroups or two different modes of hydrophobic packing in the acyl chain region.
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6.3.3 GM1 in Model Lipid Rafts
Using the same method of excess GM1 incubation that we use to prepare GM1-
enriched SOPC membranes, we also incorporate GM1 into SLBs of
cholesterol/BSM/DOPC. We prepare these SLBs with model lipid rafts by varying the
cholesterol concentration and using an equimolar ratio of BSM and DOPC. After
incubating the SLBs in GMI for 4 h, we observe dark spots that exclude TR-DPPE that
are not present before GMI incubation. Figure 6-6 compares a homogenous SLB before
incubation (a) with SLBs of different cholesterol concentrations after GMI incubation,
after the dark spots form (b-d).
Figure 6-6. Dark defects in membranes (b-d) appear after 4 h
incubation with excess GM1. (a): Before GM1 addition, the SLB of 30
mol % cholesterol, 1:1 DOPC/BSM shows no microsopic features. (b-
d): SLBs after GM1 incubation with 1:1 DOPC/BSM molar ratio and
(b) 20, (c) 30, and (d) 40 mol % cholesterol. Scale bars are 10 pm.
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The dark spots remain upon heating to above 70 0 C, though fluid membranes of
these lipid mixtures do not exhibit lipid phase coexistence separation above -50'C [148].
The stability of the dark spots, combined with their strong exclusion of the dye, suggests
that they are membrane defects. Previous experiments show that defects in lipid bilayers
at the solid interface can be induced by increasing the tension in the membrane, or
reducing the lateral pressure [155]. A defect-inducing mechanism of GM1 could be
condensation, whereby the GM1 has an attractive interaction with adjacent lipids; and to
accommodate the local packing of lipids due to this interaction, pinholes in the membrane
are formed. An attractive electrostatic interaction observed previously in
cholesterol/DOPC/BSM mixtures containing GM 1 occurs between the sialic acid of GM I
and the positively-charged choline headgroups of DOPC and BSM [145].
We explore this possibility of membrane condensation due to GM1 in model lipid
raft membrane mixtures with fluorescence microscopy and we measure the diffusion
constants of cholesterol-enriched SLBs using the continuous bleaching method [81].
Figure 6-7 compares the fluorescence intensity line profiles of an SLB with 20 mol %
cholesterol, 1:1 (DOPC/BSM) (Figure 6-7, a, blue line) with the same SLB after
incubation with excess GM1 (Figure 6-7, b, red line). The narrower bright rim outlining
the illuminated region of the SLB after GMI incubation (Figure 6-7, b) compared to the
rim before GM1 incubation (Figure 6-7, a) shows the reduction of diffusion of TR-DPPE
after GM1 incubation.
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Figure 6-7. Incubation with excess GM1 reduces membrane fluidity.
Line profiles after 25 min of continuous bleaching of SLBs from 30
mol % cholesterol, 1:1 DOPC/BSM before (a, blue) and after
incubation with excess GM1 (b, red).
We use the continuous bleaching method outlined in Chapter 5 to measure the
diffusion of TR-DPPE in SLBs with model lipid rafts before and after GM 1I incubation at
three different lipid compositions. Figure 6-8 presents our diffusion measurements for
SLBs with an equimolar ratio of DOPC and BSM and 20, 30 and 40 mol% cholesterol.
The diffusion constants we measure for cholesterol/DOPC/BSM membranes show the
general trend that diffusion is reduced as the concentration of cholesterol is increased.
Upon addition of GM1, the lipid diffusion constants are reduced by -50 %, suggesting
that the SLBs enriched in GM 1 are more tightly packed than those lacking GM1.
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Figure 6-8. Diffusion constants of SLBs with varying cholesterol
concentration and 1:1 molar ration BSM/DOPC measured by
continuous bleaching without (black, circles) and with (red, triangles)
GM1.
The reduction in the mobility of homogeneous membranes after addition of GM1
is well-established [18, 143, 144]; however, in heterogeneous membranes, where GM1
may influence lipid phase separation [17, 18], lipid diffusion is more complicated. If
nanoscopic lipid domains are present, we expect the diffusion to be different between
these two domains [4]. And if GM1 changes the lipid phase transitions, then the quantity
of the lipid domains and the lipid packing within the domains would also be affected.
Gel-phase domains in lipid membranes reduce the fluidity of the surrounding liquid
domains as a function of area coverage by creating obstacles for lipid movement [49].
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The interplay of these different effects can contribute to the reduction of mobility caused
by GM1 in the cholesterol-enriched SLBs.
X-Ray reflectivity allows us to investigate the effect of GM 1 on lipid membranes
containing model lipid rafts at the molecular level. When we incorporate GM1 into the
membrane, we see behavior that is qualitatively similar to the SOPC/GM 1 system, as the
first minima is shifted towards a lower qz, indicating a thickening of the layer. Figure 6-9
shows the reflectivity and electron density profiles of the same cholesterol/BSM/DOPC
membranes in Figure 6-5 after they have been incubated with excess GM1. The
asymmetry of the effect of GMI is apparent, as only the upper leaflet away from the
substrate shows major modifications. At each composition, the outer headgroups are
shifted away from the membrane. The outer headgroup density profile of the 20 mol %
cholesterol SLB is only partially shifted (Figure 6-9, b, II), as part of the headgroup
profile is centered near its pre-GM 1 position of -45 A from the substrate. The reflectivity
indicates a smearing effect of the second minima (Figure 6-9, a), which may be due to
destructive interference from heterogeneous structures within the membrane.
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Figure 6-9. Reflectivity (a) and electron density profiles (b) of SLBs
after GM1 incubation. SLBs composed of fixed 1:1 BSM/DOPC molar
ratio and cholesterol concentrations of (I, red) 20, (II, green) 30, and
(III, blue) 40 mol %.
134
6.4 Conclusions
The incorporation of GMI into supported lipid membranes stretches the outer
membrane leaflet and increases the lipid headgroup density, consistent with a structural
effect of the GM1 headgroup protruding out from the membrane surface. By observing
this stretching effect in a homogeneous fluid membrane, we clearly demonstrate the
asymmetric insertion of GM1. Heterogeneous lipid bilayers that are able to phase
separate into ordered and disordered liquid phases are, however, more representative of
cell membranes than homogeneous bilayers. Therefore, we examine SLBs of cholesterol,
BSM and DOPC at a solid support. We show that the onset of microscopic phase
separation can be influenced by the substrate roughness and that cholesterol has a
thickening effect on the membrane. The inclusion of GMI reduces the lipid diffusion of
cholesterol-enriched membranes and introduces defects, suggesting membrane
condensation due to GM1 interactions with other lipids. Reflectivity offers an opportunity
to systematically study how receptor molecules influence lipid packing and arrangement
within membranes.
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